<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dietary interventions for recurrent abdominal pain in childhood - Newlove‐Delgado, TV - 2017 | Cochrane Library</title> <meta content="Dietary interventions for recurrent abdominal pain in childhood - Newlove‐Delgado, TV - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010972.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dietary interventions for recurrent abdominal pain in childhood - Newlove‐Delgado, TV - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010972.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010972.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Dietary interventions for recurrent abdominal pain in childhood" name="citation_title"/> <meta content="Tamsin V Newlove‐Delgado" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="tamsinnewlove1@nhs.net" name="citation_author_email"/> <meta content="Alice E Martin" name="citation_author"/> <meta content="Royal Devon and Exeter Hospital" name="citation_author_institution"/> <meta content="Rebecca A Abbott" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Alison Bethel" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Joanna Thompson‐Coon" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Rebecca Whear" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Stuart Logan" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD010972.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/03/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010972.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010972.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010972.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Diet, Carbohydrate‐Restricted; Abdominal Pain [*diet therapy]; Dietary Fiber [*therapeutic use]; Fructose; Irritable Bowel Syndrome [diet therapy]; Pain Measurement; Probiotics [*therapeutic use]; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention [methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010972.pub2&amp;doi=10.1002/14651858.CD010972.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="UDgTyLGV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010972\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010972\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","fr","pl","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010972.pub2",title:"Dietary interventions for recurrent abdominal pain in childhood",firstPublishedDate:"Mar 23, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010972.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010972.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010972.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010972.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010972.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010972.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010972.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010972.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010972.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010972.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5388 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010972.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0152"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0063"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-sec-0142"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/appendices#CD010972-sec-0157"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/table_n/CD010972StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/table_n/CD010972StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dietary interventions for recurrent abdominal pain in childhood</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Tamsin V Newlove‐Delgado</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0003">Alice E Martin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0004">Rebecca A Abbott</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0005">Alison Bethel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0006">Joanna Thompson‐Coon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0007">Rebecca Whear</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information#CD010972-cr-0008">Stuart Logan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information/en#CD010972-sec-0175">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 March 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010972.pub2">https://doi.org/10.1002/14651858.CD010972.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010972-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010972-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010972-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010972-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010972-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010972-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010972-abs-0001" lang="en"> <section id="CD010972-sec-0001"> <h3 class="title" id="CD010972-sec-0001">Background</h3> <p>This is an update of the original Cochrane review, last published in 2009 (Huertas‐Ceballos 2009). Recurrent abdominal pain (RAP), including children with irritable bowel syndrome, is a common problem affecting between 4% and 25% of school‐aged children. For the majority of such children, no organic cause for their pain can be found on physical examination or investigation. Many dietary inventions have been suggested to improve the symptoms of RAP. These may involve either excluding ingredients from the diet or adding supplements such as fibre or probiotics. </p> </section> <section id="CD010972-sec-0002"> <h3 class="title" id="CD010972-sec-0002">Objectives</h3> <p>To examine the effectiveness of dietary interventions in improving pain in children of school age with RAP. </p> </section> <section id="CD010972-sec-0003"> <h3 class="title" id="CD010972-sec-0003">Search methods</h3> <p>We searched CENTRAL, Ovid MEDLINE, Embase, eight other databases, and two trials registers, together with reference checking, citation searching and contact with study authors, in June 2016. </p> </section> <section id="CD010972-sec-0004"> <h3 class="title" id="CD010972-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing dietary interventions with placebo or no treatment in children aged five to 18 years with RAP or an abdominal pain‐related, functional gastrointestinal disorder, as defined by the Rome III criteria (Rasquin 2006). </p> </section> <section id="CD010972-sec-0005"> <h3 class="title" id="CD010972-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane. We grouped dietary interventions together by category for analysis. We contacted study authors to ask for missing information and clarification, when needed. We assessed the quality of the evidence for each outcome using the GRADE approach. </p> </section> <section id="CD010972-sec-0006"> <h3 class="title" id="CD010972-sec-0006">Main results</h3> <p>We included 19 RCTs, reported in 27 papers with a total of 1453 participants. Fifteen of these studies were not included in the previous review. All 19 RCTs had follow‐up ranging from one to five months. Participants were aged between four and 18 years from eight different countries and were recruited largely from paediatric gastroenterology clinics. The mean age at recruitment ranged from 6.3 years to 13.1 years. Girls outnumbered boys in most trials. Fourteen trials recruited children with a diagnosis under the broad umbrella of RAP or functional gastrointestinal disorders; five trials specifically recruited only children with irritable bowel syndrome. The studies fell into four categories: trials of probiotic‐based interventions (13 studies), trials of fibre‐based interventions (four studies), trials of low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diets (one study), and trials of fructose‐restricted diets (one study). </p> <p>We found that children treated with probiotics reported a greater reduction in pain frequency at zero to three months postintervention than those given placebo (standardised mean difference (SMD) ‐0.55, 95% confidence interval (CI) ‐0.98 to ‐0.12; 6 trials; 523 children). There was also a decrease in pain intensity in the intervention group at the same time point (SMD ‐0.50, 95% CI ‐0.85 to ‐0.15; 7 studies; 575 children). However, we judged the evidence for these outcomes to be of low quality using GRADE due to an unclear risk of bias from incomplete outcome data and significant heterogeneity. </p> <p>We found that children treated with probiotics were more likely to experience improvement in pain at zero to three months postintervention than those given placebo (odds ratio (OR) 1.63, 95% CI 1.07 to 2.47; 7 studies; 722 children). The estimated number needed to treat for an additional beneficial outcome (NNTB) was eight, meaning that eight children would need to receive probiotics for one to experience improvement in pain in this timescale. We judged the evidence for this outcome to be of moderate quality due to significant heterogeneity. </p> <p>Children with a symptom profile defined as irritable bowel syndrome treated with probiotics were more likely to experience improvement in pain at zero to three months postintervention than those given placebo (OR 3.01, 95% CI 1.77 to 5.13; 4 studies; 344 children). Children treated with probiotics were more likely to experience improvement in pain at three to six months postintervention compared to those receiving placebo (OR 1.94, 95% CI 1.10 to 3.43; 2 studies; 224 children). We judged the evidence for these two outcomes to be of moderate quality due to small numbers of participants included in the studies. </p> <p>We found that children treated with fibre‐based interventions were not more likely to experience an improvement in pain at zero to three months postintervention than children given placebo (OR 1.83, 95% CI 0.92 to 3.65; 2 studies; 136 children). There was also no reduction in pain intensity compared to placebo at the same time point (SMD ‐1.24, 95% CI ‐3.41 to 0.94; 2 studies; 135 children). We judged the evidence for these outcomes to be of low quality due to an unclear risk of bias, imprecision, and significant heterogeneity. </p> <p>We found only one study of low FODMAP diets and only one trial of fructose‐restricted diets, meaning no pooled analyses were possible. </p> <p>We were unable to perform any meta‐analyses for the secondary outcomes of school performance, social or psychological functioning, or quality of daily life, as not enough studies included these outcomes or used comparable measures to assess them. </p> <p>With the exception of one study, all studies reported monitoring children for adverse events; no major adverse events were reported. </p> </section> <section id="CD010972-sec-0007"> <h3 class="title" id="CD010972-sec-0007">Authors' conclusions</h3> <p>Overall, we found moderate‐ to low‐quality evidence suggesting that probiotics may be effective in improving pain in children with RAP. Clinicians may therefore consider probiotic interventions as part of a holistic management strategy. However, further trials are needed to examine longer‐term outcomes and to improve confidence in estimating the size of the effect, as well as to determine the optimal strain and dosage. Future research should also explore the effectiveness of probiotics in children with different symptom profiles, such as those with irritable bowel syndrome. </p> <p>We found only a small number of trials of fibre‐based interventions, with overall low‐quality evidence for the outcomes. There was therefore no convincing evidence that fibre‐based interventions improve pain in children with RAP. Further high‐quality RCTs of fibre supplements involving larger numbers of participants are required. Future trials of low FODMAP diets and other dietary interventions are also required to facilitate evidence‐based recommendations. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010972-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010972-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010972-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010972-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010972-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010972-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010972-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010972-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010972-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010972-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010972-abs-0004" lang="en"> <h3>Dietary interventions for recurrent abdominal pain in children</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence on the effects of dietary interventions on pain in children aged between five and 18 years with recurrent abdominal pain (RAP). </p> <p><b>Background</b> </p> <p>Recurrent abdominal pain, or RAP, is a term used for unexplained episodes of stomachache or abdominal pain in children. Recurrent abdominal pain is a common condition, and most children are likely to be helped by simple measures. However, a range of treatments have been recommended to relieve abdominal pain, including making changes to the child's eating habits by adding supplements or excluding certain foods. </p> <p><b>Study characteristics</b> </p> <p>This evidence is current to June 2016.</p> <p>Nineteen studies met our inclusion criteria, including 13 studies of probiotics and four studies of fibre interventions. We also found one study of a diet low in substances known as FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) and one study of a fructose‐restricted diet. </p> <p>All of the studies compared dietary interventions to a placebo or control. The trials were carried out in eight countries and included a total of 1453 participants, aged between five and 18 years. Most children were recruited from outpatient clinics. Most interventions lasted four to six weeks. </p> <p><b>Key results</b> </p> <p><i>Probiotics</i> </p> <p>We found evidence from 13 studies suggesting that probiotics might be effective in improving pain in the shorter term. Most studies did not report on other areas such as quality of daily life. No harmful effects were reported, other than dry mouth in one study. We judged this evidence to be of moderate or low quality because some studies were small, showed varying results, or were at risk of bias. </p> <p><i>Fibre supplements</i> </p> <p>We found no clear evidence of improvement of pain from four studies of fibre supplements. Most studies did not report on other areas such as quality of daily life. No harmful effects were reported. There were few studies of fibre supplements, and some of these studies were at risk of bias. We judged this evidence to be of low quality. </p> <p><i>Low FODMAP diets</i> </p> <p>We found only one study evaluating the effectiveness of low FODMAP diets in children with RAP. </p> <p><i>Fructose‐restricted diets</i> </p> <p>We found only one study evaluating the effectiveness of fructose‐restricted diets in children with RAP. </p> <p><b>Conclusion</b> </p> <p>We found some evidence suggesting that probiotics may be helpful in relieving pain in children with RAP in the short term. Clinicians may therefore consider probiotic interventions as part of the management strategy for RAP. Further trials are needed to find out how effective probiotics are over longer periods of time and which probiotics might work best. </p> <p>We did not find convincing evidence that fibre supplements are effective in improving pain in children with RAP. Future larger, high‐quality studies are needed to test the effectiveness of fibre and low FODMAP diet treatments. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010972-sec-0152" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010972-sec-0152"></div> <h3 class="title" id="CD010972-sec-0153">Implications for practice</h3> <section id="CD010972-sec-0153"> <p>Overall, there is some evidence to suggest that probiotics may be effective in the treatment of RAP, in terms of improving pain in the shorter term. Clinicians may therefore consider probiotic interventions as part of the management strategy for children with RAP. However, we were unable to recommend the optimum strain and dosage of probiotic based on this review. </p> <p>We did not find convincing evidence that fibre interventions were effective in improving pain in children with RAP. The evidence for other dietary interventions (e.g. low FODMAP or lactose‐ or fructose‐free diets) is also currently lacking, therefore we were unable to make evidence‐based recommendations regarding their use in practice. For a holistic approach, the evidence from this review regarding the effectiveness of dietary interventions should also be considered in conjunction with evidence from the companion Cochrane reviews covering pharmacological interventions, <a href="./references#CD010972-bbs2-0060" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , WhearR , et al. Pharmacological interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD010973.pub2] ">Martin 2014a</a>, and psychosocial interventions, <a href="./references#CD010972-bbs2-0027" title="AbbottRA , MartinAE , Newlove‐DelgadoTV , BethelA , Thompson‐CoonJ , WhearR , et al. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010971.pub2] ">Abbott 2017</a>, for RAP in childhood. </p> </section> <h3 class="title" id="CD010972-sec-0154">Implications for research</h3> <section id="CD010972-sec-0154"> <p>The evidence for the effectiveness of probiotics was based largely on shorter‐term outcomes. Further trials are required to assess whether improvements in pain are maintained over the longer term; these trials should also consider the importance of using validated and consistent scales to measure pain and other outcomes. Such studies could attempt to examine the effects of probiotics on a wider range of outcomes important to children and their parents, such as quality of life, school attendance, and disability. Future research should also address the question of the optimal strain and dosage schedule for probiotic interventions, as well as consider the effectiveness of probiotics in different settings (the majority of these studies were conducted in gastroenterology clinics in Europe). It has been suggested that there are distinct subtypes of RAP and that these could guide treatment choice (<a href="./references#CD010972-bbs2-0039" title="DrossmanDA , ChangL , CheyWD , KellowJ , TackJ , WhiteheadWE . Rome IV Functional Gastrointestinal Disorders: Disorders of Gut‐Brain Interaction. Raleigh (NC): Rome Foundation, 2016. ">Drossman 2016</a>). We therefore thought it important in this review to estimate whether subtype predicted response to different treatment modalities, however this needs further investigation to allow a tailored approach to management. </p> <p>In the case of fibre‐based interventions and low FODMAP and other exclusion diets, further high‐quality RCTs involving larger numbers of participants are needed to examine the effectiveness of these interventions. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010972-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010972-sec-0029"></div> <div class="table" id="CD010972-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Probiotics compared to placebo for recurrent abdominal pain in childhood</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Probiotics compared to placebo for recurrent abdominal pain in childhood</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Children with recurrent abdominal pain<br/> <b>Settings:</b> Mixed settings, including paediatric gastroenterology clinics<br/> <b>Intervention:</b> Probiotics<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in pain frequency: 0 to 3 months' postintervention</b> </p> <p>Different measures were used to assess pain frequency, such as a visual analogue scale and the Wong‐Baker FACES Pain Rating Scale (<a href="./references#CD010972-bbs2-0061" title="McGrathPA , SeifertCE , SpeechleyKN , BoothJC , StittL , GibsonMC . A new analogue scale for assessing children's pain: an initial validation study. Pain1996;64(3):435‐43. [PUBMED: 8783307] ">McGrath 1996</a>; <a href="./references#CD010972-bbs2-0097" title="WongD , BakerC . Pain in children: comparison of assessment scales. Pediatric Nursing1988;14(1):9‐17. [PUBMED: 3344163] ">Wong 1988</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain frequency: 0 to 3 months' postintervention scores in the intervention groups was <b>0.55 SDs lower</b> (0.98 to 0.12 lower). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>523<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SD represents a small difference, 0.5 SD a moderate difference, and 0.8 SD a large difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in pain intensity: 0 to 3 months' postintervention</b> </p> <p>Different measures were used to assess pain intensity, as above.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain intensity: 0 to 3 months' postintervention scores in the intervention groups was <b>0.50 SDs lower</b> (0.85 to 0.15 lower). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>575<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SD represents a small difference, 0.5 SD a moderate difference, and 0.8 SD a large difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 0 to 3 months' postintervention</b> </p> <p>Different measures and definitions were used for improvement in pain, such as Likert scale, visual analogue scale, and Subject’s Global Assessment of Relief Scale (<a href="./references#CD010972-bbs2-0061" title="McGrathPA , SeifertCE , SpeechleyKN , BoothJC , StittL , GibsonMC . A new analogue scale for assessing children's pain: an initial validation study. Pain1996;64(3):435‐43. [PUBMED: 8783307] ">McGrath 1996</a>; <a href="./references#CD010972-bbs2-0063" title="Müller‐LissnerS , KochG , TalleyNJ , DrossmanD , RueeggP , Dunger‐BaldaufC , et al. Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome‐related symptoms in clinical trials. Journal of Clinical Epidemiology2003;56(4):310‐6. [PUBMED: 12767407] ">Muller‐Lissner 2003</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>421 per 1000</b><sup>3</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>542 per 1000</b> <br/> (438 to 642) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.63</b> <br/> (1.07 to 2.47) </p> <p>NNTB = 8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>722<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 0 to 3 months' postintervention Subgroup (irritable bowel syndrome)</b> </p> <p>Different measures were used to assess improvement in pain, as above.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>359 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>627 per 1000</b> <br/> (498 to 742) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 3.01</b> <br/> (1.77 to 5.13) </p> <p>NNTB = 4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>344<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 3 to 6 months' postintervention</b> </p> <p>Different measures were used to assess improvement in pain, as above.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>589 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>736 per 1000</b> <br/> (612 to 831) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.94</b> <br/> (1.10 to 3.43) </p> <p>NNTB = 7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>224<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NNTB</b> : number needed to treat for an additional beneficial outcome, based on the absolute risk reduction between the intervention and comparison group probable outcomes; <b>OR:</b> odds ratio; <b>SD:</b> standard deviation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to incomplete outcome data in a number of included studies leading to an unclear or high risk of bias.<br/> <sup>2</sup>Downgraded one level for evidence of significant heterogeneity (I² &gt; 70%; Chi² P &lt; 0.001).<br/> <sup>3</sup>Assumed risk is based on the mean outcome of the control groups in all included studies.<br/> <sup>4</sup>Downgraded one level due to evidence of heterogeneity (I² = 45%; Chi² P = 0.09).<br/> <sup>5</sup>Downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010972-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Fibre versus placebo for recurrent abdominal pain in childhood</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fibre versus placebo for recurrent abdominal pain in childhood</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Children with recurrent abdominal pain<br/> <b>Settings:</b> Mixed settings, predominantly outpatient gastroenterology clinics<br/> <b>Intervention:</b> Fibre </p> <p><b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Fibre</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in pain intensity: 0 to 3 months' postintervention</b> </p> <p>Pain intensity was measured using different scales in the 2 included studies: the Wong Baker FACES Pain Rating Scale, <a href="./references#CD010972-bbs2-0097" title="WongD , BakerC . Pain in children: comparison of assessment scales. Pediatric Nursing1988;14(1):9‐17. [PUBMED: 3344163] ">Wong 1988</a>, and the Numerical Rating Scale (<a href="./references#CD010972-bbs2-0092" title="vonBaeyerCL , SpagrudLJ , McCormickJC , ChooE , NevilleK , ConnellyMA . Three new datasets supporting use of the Numerical Rating Scale (NRS‐11) for children’s self‐reports of pain intensity. Pain2009;143(3):223‐7. [DOI: 10.1016/j.pain.2009.03.002; PUBMED: 19359097] ">von Baeyer 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain intensity 0 to 3 months' postintervention score in the intervention groups was <b>1.24 SDs lower</b> (3.41 lower to 0.94 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 0 to 3 months' postintervention</b> </p> <p>Improvement in pain was defined and measured differently in the 2 included studies: using a "stomach ache diary" and the Faces Pain Scale (<a href="./references#CD010972-bbs2-0034" title="BieriD , ReeveR , ChampionGD , AddicoatL , ZieglerJ . The Faces Pain Scale for the self‐assessment of the severity of pain experienced by children: development, initial validation and preliminary investigation for ratio scale properties. Pain1990;41:139‐50. [PUBMED: 2367140] ">Bieri 1990</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>391 per 1000</b><sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>541 per 1000</b> <br/> (372 to 701) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.83</b> <br/> (0.92 to 3.65) </p> <p>NNTB = 6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NNTB:</b> number needed to treat for an additional beneficial outcome, based on the absolute risk reduction between the intervention and comparison group probable outcomes; <b>OR:</b> odds ratio; <b>SD:</b> standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Assumed risk in control group is based on the mean outcome of the control group in the two included studies.<br/> <sup>2</sup>Downgraded one level due to imprecision.<br/> <sup>3</sup>Downgraded one level due to evidence of significant heterogeneity.<br/> <sup>4</sup>Downgraded one level, as one study contained insufficient information regarding allocation concealment, outcome assessment, and selective reporting. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010972-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010972-sec-0030"></div> <section id="CD010972-sec-0031"> <h3 class="title" id="CD010972-sec-0031">Description of the condition</h3> <p>This review is an update of a previously published review in the Cochrane Library on 'Psychosocial interventions for recurrent abdominal pain and irritable bowel syndrome in childhood' (<a href="./references#CD010972-bbs2-0100" title="Huertas‐CeballosA , LoganS , BennettC , MacarthurC . Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3] ">Huertas‐Ceballos 2009</a>). Recurrent abdominal pain (RAP) is a common problem in paediatric practice. It has been suggested that 4% to 25% of school‐aged children will at some point suffer from recurrent or chronic abdominal pain that interferes with their activities of daily living (<a href="./references#CD010972-bbs2-0057" title="KonijnenbergAY , UiterwaalCS , KimpenJL , van derHoevenJ , BuitelaarJK , deGraeff‐MeederER . Children with unexplained chronic pain: substantial impairment in everyday life. Archives of Disease in Childhood2005;90(7):680‐6. [DOI: 10.1136/adc.2004.056820; PMC1720481; PUBMED: 15899922] ">Konijnenberg 2005</a>; <a href="./references#CD010972-bbs2-0096" title="WilliamsK , ChambersM , LoganS , RobinsonD . Association of common health symptoms with bullying in primary school children. BMJ1996;313(7048):17‐9. [PMC2351438] ">Williams 1996</a>; <a href="./references#CD010972-bbs2-0098" title="YoussefNN , MurphyTG , LangsederAL , RoshJR . Quality of life for children with functional abdominal pain: a comparison study of patients’ and parents’ perceptions. Pediatrics2006;117(1):54‐9. [DOI: 10.1542/peds.2005‐0114; PUBMED: 16396860] ">Youssef 2006</a>), with a recent meta‐analysis estimating that 13.5% of children worldwide may be affected (<a href="./references#CD010972-bbs2-0058" title="KorterinkJJ , DiederenK , BenningaMA , TabbersMM . Epidemiology of pediatric functional abdominal pain disorders: a meta‐analysis. PLoS One2015;10(5):e0126982. [DOI: 10.1371/journal.pone.0126982; PMC4439136; PUBMED: 25992621] ">Korterink 2015</a>). Recurrent abdominal pain is often regarded as a relatively benign condition, but it is important to note the associated morbidity and the anxiety it causes for children and caregivers (<a href="./references#CD010972-bbs2-0066" title="PaulSP , CandyDC . Clinical update: recurrent abdominal pain in children. Community Practice2013;86(11):48‐51. [PUBMED: 24369571] ">Paul 2013</a>). The condition is associated with school absences, hospital admissions, emotional disorders and, on occasion, unnecessary surgical intervention (<a href="./references#CD010972-bbs2-0077" title="ScharffL . Recurrent abdominal pain in children: a review of psychological factors and treatment. Clinical Psychology Review1997;17(2):145‐66. [PUBMED: 9140713] ">Scharff 1997</a>; <a href="./references#CD010972-bbs2-0082" title="SticklerGB , MurphyDB . Recurrent abdominal pain. American Journal of Diseases in Children1979;133(5):486‐9. [PUBMED: 433872] ">Stickler 1979</a>; <a href="./references#CD010972-bbs2-0085" title="StørdalK , NygaardE , BentsenB . Recurrent abdominal pain: a five‐year follow‐up study. Acta Paediatrica2005;94(2):234‐6. [PUBMED: 15981760] ">Størdal 2005</a>; <a href="./references#CD010972-bbs2-0093" title="WalkerLS , GuiteJW , DukeM , BarnardJA , GreeneJW . Recurrent abdominal pain: a potential precursor of irritable bowel syndrome in adolescents and young adults. Journal of Pediatrics1998;132(6):1010‐5. [PUBMED: 9627595] ">Walker 1998</a>; <a href="./references#CD010972-bbs2-0099" title="YoussefNN , AtienzaK , LangsederAL , StraussRS . Chronic abdominal pain and depressive symptoms: analysis of the national longitudinal study of adolescent health. Clinical Gastroenterology and Hepatology2008;6(3):329‐32. [DOI: 10.1016/j.cgh.2007.12.019; PUBMED: 18258491] ">Youssef 2008</a>). The abdominal pain is also commonly associated with other symptoms, including headaches, recurrent limb pains, pallor, and vomiting (<a href="./references#CD010972-bbs2-0028" title="Abu‐ArafehI , RussellG . Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Archives of Disease in Childhood1995;72(5):413‐7. [PMC1511089] ">Abu‐Arafeh 1995</a>; <a href="./references#CD010972-bbs2-0037" title="DevanarayanaNM , MettanandaS , LiyanarachchiC , NanayakkaraN , MendisN , PereraN , et al. Abdominal pain‐predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. Journal of Pediatric Gastroenterology and Nutrition2011;53(6):659‐65. [DOI: 10.1097/MPG.0b013e3182296033; PUBMED: 21697745] ">Devanarayana 2011</a>; <a href="./references#CD010972-bbs2-0056" title="HyamsJS , TreemWR , JustinichCJ , DavisP , ShoupM , BurkeG . Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition1995;20(2):209‐14. [PUBMED: 7714688] ">Hyams 1995</a>). Symptoms sometimes continue into adulthood; childhood RAP is associated with a higher risk of anxiety disorders in adults (<a href="./references#CD010972-bbs2-0051" title="HorstS , ShelbyG , AndersonJ , AcraS , PolkDB , SavilleBR , et al. Predicting persistence of functional abdominal pain from childhood into young adulthood. Clinical Gastroenterology and Hepatology2014;12(12):2026‐32. [DOI: 10.1016/j.cgh.2014.03.034; PMC4195814; PUBMED: 24732284] ">Horst 2014</a>; <a href="./references#CD010972-bbs2-0080" title="ShelbyGD , ShirkeyKC , ShermanAL , BeckJE , HamanK , ShearsAR , et al. Functional abdominal pain in childhood and long‐term vulnerability to anxiety disorders. Pediatrics2013;132(3):2012‐91. [DOI: 10.1542/peds.2012‐2191] ">Shelby 2013</a>). </p> <p>Apley first sought to define the condition in the 1950s and suggested that the diagnostic label should be based on the presence of at least three episodes of severe abdominal pain (often, but not necessarily, with associated systemic symptoms) over three months (<a href="./references#CD010972-bbs2-0029" title="ApleyJ , NaishN . Recurrent abdominal pains: a field survey of 1000 school children. Archives of Disease in Childhood1958;33(168):165‐70. [PMC2012205] ">Apley 1958</a>), with no established organic cause. Historically diverse terms have since been used to describe these conditions, some implying causation. These include: "abdominal migraine" (<a href="./references#CD010972-bbs2-0031" title="BainH . Chronic vague abdominal pain in children. Pediatric Clinics of North America1974;21(4):991‐1000. [PUBMED: 4427792] ">Bain 1974</a>; <a href="./references#CD010972-bbs2-0041" title="FarquarHG . Abdominal migraine in children. British Medical Journal1956;1(4975):1082‐5. [PMC1979859] ">Farquar 1956</a>; <a href="./references#CD010972-bbs2-0050" title='HockadayJM . Is there a place for "abdominal migraine" as a separate entity in the IHS classification? No!. Cephalalgia1992;12(6):346‐8. '>Hockaday 1992</a>; <a href="./references#CD010972-bbs2-0088" title="SymonDNK , RussellG . Abdominal migraine: a childhood syndrome defined. Cephalalgia1986;6(4):223‐8. ">Symon 1986</a>), "abdominal epilepsy" (<a href="./references#CD010972-bbs2-0084" title="StowensD . Recurrent abdominal pain. Pediatrics1970;46(6):968‐9. ">Stowens 1970</a>), "the irritable bowel syndrome in childhood" (<a href="./references#CD010972-bbs2-0083" title="StoneRT , BarberoGJ . Recurrent abdominal pain in childhood. Pediatrics1970;45(5):732‐8. ">Stone 1970</a>), "allergic‐tension‐fatigue syndrome" (<a href="./references#CD010972-bbs2-0076" title="SandbergDH . Additional references on the tension‐fatigue syndrome. Pediatrics1973;51(2):308‐9. ">Sandberg 1973</a>; <a href="./references#CD010972-bbs2-0081" title="SpeerF . The allergic tension‐fatigue syndrome. Pediatric Clinics of North America1954;11:1029‐38. [PUBMED: 13204094] ">Speer 1954</a>), "neurovegetative dystonia" (<a href="./references#CD010972-bbs2-0067" title="PeltonenT . Recurrent abdominal pain. Pediatrics1970;46(6):973. ">Peltonen 1970</a>; <a href="./references#CD010972-bbs2-0074" title="RubinLS , BarberoGL , SibingaMS . Pupillary reactivity in children with recurrent abdominal pain. Psychosomatic Medicine1967;29(2):111‐20. [PUBMED: 6030151] ">Rubin 1967</a>), "functional gastrointestinal disorder" (<a href="./references#CD010972-bbs2-0038" title="DrossmanDA , CreedFH , FavaGA , OldenKW , PatrickDL , TonerBB , et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology International1995;8(2):47‐90. ">Drossman 1995</a>), and "the irritated colon syndrome" (<a href="./references#CD010972-bbs2-0044" title="HarveyRF , PomareEW , HeatonKW . Effects of increased dietary fibre on intestinal transit. Lancet1973;1(7815):1278‐80. [DOI: 10.1016/S0140‐6736(73)91294‐4] ">Harvey 1973</a>; <a href="./references#CD010972-bbs2-0065" title="PainterNS , TrueloveSC . Irritable bowel syndrome in childhood. Gut1964;5:201. ">Painter 1964</a>). </p> <p>It is now generally accepted that RAP in children represents a group of functional gastrointestinal disorders that have an unclear aetiology. The latest Rome Foundation criteria state that such disorders are defined by symptoms related to motility disturbance; visceral hypersensitivity; altered mucosal and immune function; altered gut microbiota; and altered central nervous system processing, and are "the product of ... interactions of psychosocial factors and altered gut physiology via the brain–gut axis" (<a href="./references#CD010972-bbs2-0039" title="DrossmanDA , ChangL , CheyWD , KellowJ , TackJ , WhiteheadWE . Rome IV Functional Gastrointestinal Disorders: Disorders of Gut‐Brain Interaction. Raleigh (NC): Rome Foundation, 2016. ">Drossman 2016</a>). The Rome Foundation has produced criteria for this group of conditions since 1994 by international consensus. Most studies included in this review use the Rome III criteria from 2006, which included a symptom‐based classification system with specific categories for paediatric presentations (<a href="./references#CD010972-bbs2-0070" title="RasquinA , DiLorenzoC , ForbesD , GuiraldesE , HyamsJS , StaianoA , et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology2006;130(5):1527–37. [DOI: 10.1053/j.gastro.2005.08.063; PUBMED: 16678566] ">Rasquin 2006</a>). Throughout this review we have therefore used RAP as an umbrella term to refer to the five subcategories included within the Rome III category of childhood abdominal pain‐related functional gastrointestinal disorders, which are: functional dyspepsia, irritable bowel syndrome, abdominal migraine, functional abdominal pain, and functional abdominal pain syndrome. It should be noted that the pain classification for each of the Rome III diagnoses is defined by at least one episode per week for at least two months; this varies from Apley's original definition of RAP (<a href="./references#CD010972-bbs2-0029" title="ApleyJ , NaishN . Recurrent abdominal pains: a field survey of 1000 school children. Archives of Disease in Childhood1958;33(168):165‐70. [PMC2012205] ">Apley 1958</a>). The Rome IV criteria were produced in spring 2016; in this new iteration the category of childhood functional abdominal pain disorders includes functional dyspepsia, irritable bowel syndrome, abdominal migraine, and functional abdominal pain not otherwise specified (<a href="./references#CD010972-bbs2-0039" title="DrossmanDA , ChangL , CheyWD , KellowJ , TackJ , WhiteheadWE . Rome IV Functional Gastrointestinal Disorders: Disorders of Gut‐Brain Interaction. Raleigh (NC): Rome Foundation, 2016. ">Drossman 2016</a>). However, the Rome classification is not based on known pathophysiological differences between the conditions, but rather on the constellation of clinical features. It is unclear the extent to which separating children into these categories defines groups that are distinct clinical entities that are likely to respond differently to treatment. </p> <p>There is no consensus about which of the numerous proposed causal pathways result in the heterogeneous presentations of chronic abdominal pain, although it is suggested that physical, emotional, and environmental factors may contribute to the manifestation of unexplained abdominal pain. When considering the diverse proposed mechanisms, it is unsurprising that a variety of treatments have been suggested. The treatment approaches can be grouped as pharmacological, dietary, or psychosocial (psychological or behavioural, or both). This review focused on any intervention with dietary changes intended to improve the symptoms of RAP, and hence dietary approaches only are discussed below. Updated companion reviews of pharmacological interventions, <a href="./references#CD010972-bbs2-0060" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , WhearR , et al. Pharmacological interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD010973.pub2] ">Martin 2014a</a>, and psychosocial interventions, <a href="./references#CD010972-bbs2-0027" title="AbbottRA , MartinAE , Newlove‐DelgadoTV , BethelA , Thompson‐CoonJ , WhearR , et al. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010971.pub2] ">Abbott 2017</a>, for RAP have been published. </p> </section> <section id="CD010972-sec-0032"> <h3 class="title" id="CD010972-sec-0032">Description of the intervention</h3> <p>Dietary interventions may involve excluding or reducing a food group or specific ingredient from the diet or supplementing it and therefore increasing its intake. Such dietary interventions include eliminating or restricting food groups or food components, such as dairy products or fructose (<a href="./references#CD010972-bbs2-0031" title="BainH . Chronic vague abdominal pain in children. Pediatric Clinics of North America1974;21(4):991‐1000. [PUBMED: 4427792] ">Bain 1974</a>; <a href="./references#CD010972-bbs2-0033" title="BaylessMD , HuangSS . Recurrent abdominal pain due to milk and lactose intolerance in school‐aged children. Pediatrics1971;47(6):1029‐32. [PUBMED: 5172188] ">Bayless 1971</a>; <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>), and taking fibre supplements (<a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>). Probiotics, which are living micro‐organisms such as <i>Lactobacillus</i>, have also been used in managing children with RAP (<a href="./references#CD010972-bbs2-0095" title="WilhelmSM , BrubakerCM , VarcakEA , Kale‐PradhanPB . Effectiveness of probiotics in the treatment of irritable bowel syndrome. Pharmacology2008;28(4):496‐505. ">Wilhelm 2008</a>). More recently there has been interest in the use of low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diets in the management of irritable bowel syndrome, although the majority of studies have included adult populations (<a href="./references#CD010972-bbs2-0069" title="RaoSS , YuS , FedewaA . Systematic review: dietary fibre and FODMAP‐restricted diet in the management of constipation and irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;41(12):1256–70. [DOI: 10.1111/apt.13167; PUBMED: 25903636] ">Rao 2015</a>), with one recent randomised controlled trial in children (<a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>). </p> </section> <section id="CD010972-sec-0033"> <h3 class="title" id="CD010972-sec-0033">How the intervention might work</h3> <p>Probiotic‐based interventions containing living micro‐organisms are thought to improve symptoms through restoring the gut's microbial balance. It has also been suggested that they might alter the intestinal inflammatory response in the lining of the gut (<a href="./references#CD010972-bbs2-0068" title="QuigleyEM . Probiotics in functional gastrointestinal disorders: what are the facts?. Current Opinion in Pharmacology2008;8(6):704–8. [DOI: 10.1016/j.coph.2008.08.007; PUBMED: 18775516] ">Quigley 2008</a>). Fibre‐based interventions might be effective in children with irritable bowel syndrome in particular, by modifying bowel habits and the transit time through the gut, as well as by decreasing intracolonic pressure (<a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>). It has been suggested that alterations in diet, such as low FODMAP interventions, may work in irritable bowel syndrome by reducing osmotic effects, fermentation, and gas production, hence decreasing distension and pain (<a href="./references#CD010972-bbs2-0064" title="NanayakkaraWS , SkidmorePM , O’BrienL , WilkinsonTJ , GearryRB . Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clinical and Experimental Gastroenterology2016;9:131‐42. [DOI: 10.2147/CEG.S86798; PMC4918736; PUBMED: 27382323] ">Nanayakkara 2016</a>). </p> </section> <section id="CD010972-sec-0034"> <h3 class="title" id="CD010972-sec-0034">Why it is important to do this review</h3> <p>Recurrent abdominal pain in children is very common, and in daily clinical practice there is no consensus on which treatments to offer patients. The approach to treating RAP is therefore inconsistent. This review, an update of one last carried out in 2009 (<a href="./references#CD010972-bbs2-0100" title="Huertas‐CeballosA , LoganS , BennettC , MacarthurC . Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3] ">Huertas‐Ceballos 2009</a>), is important to establish if there is new evidence for the effectiveness of dietary interventions in children with RAP. Together with updated reviews of pharmacological interventions, <a href="./references#CD010972-bbs2-0060" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , WhearR , et al. Pharmacological interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD010973.pub2] ">Martin 2014a</a>, and psychosocial interventions, <a href="./references#CD010972-bbs2-0027" title="AbbottRA , MartinAE , Newlove‐DelgadoTV , BethelA , Thompson‐CoonJ , WhearR , et al. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD010971.pub2] ">Abbott 2017</a>, for RAP, this review can guide clinicians, patients, and their families in treatment decisions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010972-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010972-sec-0035"></div> <p>To examine the effectiveness of dietary interventions in improving pain in children of school age with RAP. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010972-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010972-sec-0036"></div> <section id="CD010972-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010972-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs).</p> </section> <section id="CD010972-sec-0039"> <h4 class="title">Types of participants</h4> <p>Children aged five to 18 years old with RAP or an abdominal pain‐related functional gastrointestinal disorder, as defined by the Rome III criteria (<a href="./references#CD010972-bbs2-0070" title="RasquinA , DiLorenzoC , ForbesD , GuiraldesE , HyamsJS , StaianoA , et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology2006;130(5):1527–37. [DOI: 10.1053/j.gastro.2005.08.063; PUBMED: 16678566] ">Rasquin 2006</a>). </p> <p>Recurrent abdominal pain is defined as at least three episodes of pain interfering with normal activities within a three‐month period. The Rome III criteria recognise five abdominal pain‐related categories: "abdominal migraine", "irritable bowel syndrome", "functional dyspepsia", "functional abdominal pain", and "functional abdominal pain syndrome" (<a href="./references#CD010972-bbs2-0070" title="RasquinA , DiLorenzoC , ForbesD , GuiraldesE , HyamsJS , StaianoA , et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology2006;130(5):1527–37. [DOI: 10.1053/j.gastro.2005.08.063; PUBMED: 16678566] ">Rasquin 2006</a>). </p> </section> <section id="CD010972-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Any dietary intervention compared to placebo, waiting list, no treatment, or standard care. </p> </section> <section id="CD010972-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD010972-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010972-list-0001"> <li> <p>Pain intensity, duration, or frequency.</p> </li> </ol> </p> <p>There is no standard method for measuring pain in this condition. Studies may use any validated measurement of pain, and may report the proportion of participants with significant improvement in pain as defined by the trial author. We expected studies to vary in their duration of postintervention follow‐up. We therefore grouped studies according to duration of follow‐up: postintervention (immediately or the earliest data available following the end of treatment), medium‐term follow‐up (three to six months' postintervention), and long‐term follow‐up (six months or longer). See <a href="#CD010972-sec-0179">Differences between protocol and review</a>. </p> </section> <section id="CD010972-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p>As measured by a validated tool:</p> <p> <ol id="CD010972-list-0002"> <li> <p>school performance (to include measures such as school functioning, behaviour, or school attendance); </p> </li> <li> <p>social or psychological functioning (to include measures such as anxiety or depression); and </p> </li> <li> <p>quality of daily life (to include measures such as quality of life or impairment to daily activities, functional disability, or activity limitations). </p> </li> </ol> </p> <p>We also reported on adverse events, where these were monitored. See <a href="#CD010972-sec-0179">Differences between protocol and review</a>. </p> <p>We presented all outcomes in <a href="./full#CD010972-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD010972-tbl-0002">summary of findings Table 2</a>. </p> </section> </section> </section> <section id="CD010972-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010972-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We ran the first literature searches in April 2013 and updated them in April 2014, March 2015, and again in June 2016. We searched the electronic databases and trial registers listed below. </p> <p> <ol id="CD010972-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 5) in the Cochrane Library, and which includes the Cochrane Developmental, Psychosocial and Learning Problems Specialised Register (searched 10 June 2016). </p> </li> <li> <p>Ovid MEDLINE In‐Process &amp; Other Non‐Indexed Citations and Ovid MEDLINE (1946 to current; searched 9 June 2016). </p> </li> <li> <p>Embase Ovid (1974 to current; searched 9 June 2016).</p> </li> <li> <p>CINAHL Healthcare Databases Advanced Search (Cumulative Index to Nursing and Allied Health Literature; 1981 to current; searched 9 June 2016). </p> </li> <li> <p>PsycINFO Ovid (1806 to current; searched 9 June 2016).</p> </li> <li> <p>ERIC ProQuest (Educational Resources Information Center; 1966 to current; searched 9 June 2016). </p> </li> <li> <p>BEI ProQuest (British Education Index; 1975 to current; searched 9 June 2016).</p> </li> <li> <p>ASSIA ProQuest (Applied Social Sciences Index and Abstracts; 1987 to current; searched 9 June 2016). </p> </li> <li> <p>AMED Healthcare Databases Advanced Search (Allied and Complementary Medicine; 1985 to current; searched 9 June 2016). </p> </li> <li> <p>LILACS (Latin American and Caribbean Literature in Health Sciences; <a href="http://lilacs.bvsalud.org/en/" target="_blank">lilacs.bvsalud.org/en</a>; searched 9 June 2016). </p> </li> <li> <p>OpenGrey (<a href="http://www.opengrey.eu/" target="_blank">opengrey.eu</a>; searched 9 June 2016). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 9 June 2016). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>; searched 9 June 2016). </p> </li> </ol> </p> <p>The search terms were revised from the original Cochrane RAP reviews (<a href="./references#CD010972-bbs2-0054" title="Huertas‐CeballosAA , LoganS , BennettC , MacarthurC . Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD003014.pub2] ">Huertas‐Ceballos 2008a</a>; <a href="./references#CD010972-bbs2-0055" title="Huertas‐CeballosAA , LoganS , BennettC , MacarthurC . Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD003017.pub2] ">Huertas‐Ceballos 2008b</a>; <a href="./references#CD010972-bbs2-0100" title="Huertas‐CeballosA , LoganS , BennettC , MacarthurC . Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3] ">Huertas‐Ceballos 2009</a>); consequently, searches were run for all available years. We used RCT filters where appropriate and imposed no language limits. We translated any non‐English language studies identified so that they could be screened and considered for inclusion. The search strategies for each database are reported in <a href="./appendices#CD010972-sec-0158">Appendix 1</a>. </p> </section> <section id="CD010972-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We used the Science Citation Index to locate relevant studies using the bibliographic details, and authors' names of relevant papers for forward and backward citations. We contacted researchers who have published studies in this field to ask for details of any relevant trials. We also checked the bibliographies of papers retrieved to establish if all pertinent references were found by our search. </p> </section> </section> <section id="CD010972-sec-0047"> <h3 class="title" id="CD010972-sec-0047">Data collection and analysis</h3> <section id="CD010972-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (TVN, AEM, RAA, AB, or RW) independently screened the titles and abstracts of studies for relevance. We obtained the full‐text reports of all potentially relevant papers and screened them for inclusion against the eligibility criteria (see <a href="#CD010972-sec-0037">Criteria for considering studies for this review</a>). Any disagreements were resolved through discussion with a third review author (JTC). We recorded our decisions in a PRISMA diagram (<a href="./references#CD010972-bbs2-0062" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. BMJ2009;339:b2535. [DOI: 10.1136/bmj.b2535] ">Moher 2009</a>). </p> </section> <section id="CD010972-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (TVN, AEM, RAA, AB, JTC, or RW) extracted the data and entered the data into Cochrane's statistical software, Review Manager 5 (<a href="./references#CD010972-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collboration, 2014. ">Review Manager 2014</a>). All review authors used the same data extraction form. We collected the following data. </p> <p> <ol id="CD010972-list-0004"> <li> <p>Study characteristics: number of participating children, inclusion and exclusion criteria, type of intervention and comparison, intervention characteristics (duration, frequency, setting), number of withdrawals. </p> </li> <li> <p>Participant characteristics: sex, age, diagnosis (e.g. RAP or other syndrome, as defined by the Rome III criteria) (<a href="./references#CD010972-bbs2-0070" title="RasquinA , DiLorenzoC , ForbesD , GuiraldesE , HyamsJS , StaianoA , et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology2006;130(5):1527–37. [DOI: 10.1053/j.gastro.2005.08.063; PUBMED: 16678566] ">Rasquin 2006</a>). </p> </li> <li> <p>Outcome measures: measurement of pain and any secondary outcomes measured. See <a href="#CD010972-sec-0041">Types of outcome measures</a>. </p> </li> </ol> </p> </section> <section id="CD010972-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias of each included study using the Cochrane 'Risk of bias' tool (<a href="./references#CD010972-bbs2-0047" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). We assessed the following categories of bias: selection bias (random sequence generation and allocation concealment), performance bias (blinding of participants and personnel), detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), reporting bias (selective reporting), and other potential sources of bias that could have altered the estimate of treatment effect; for example, any evidence of differential loss to follow‐up, whether the data collection tools were valid, whether there was sufficient power in terms of appropriate sample size, whether baseline parameters were similar, and whether data analyses were appropriate. Two review authors (TVN, AEM, RAA, AB, JTC, or RW) independently assessed and classified each study as being at 'low', 'high', or 'unclear' risk of bias across each of these domains, based on the methods detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010972-bbs2-0047" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>); see <a href="#CD010972-tbl-0003">Table 1</a> for more information. We considered a trial as having an overall low risk of bias if most of the above categories of bias were assessed as low risk of bias. </p> <div class="table" id="CD010972-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Assessment of risk of bias in included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Domain</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>'Risk of bias' judgement</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Unclear</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Selection bias </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random sequence generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details any of the following methods: simple randomisation (such as coin‐tossing, throwing dice, or dealing previously shuffled cards, a list of random numbers, or computer‐generated random numbers) or restricted randomisation (blocked, ideally with varying block sizes or stratified groups, provided that within‐groups randomisation is not affected). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details no randomisation or other inadequate method such as alternation, assignment based on date of birth, case record number, and date of presentation. These may be referred to as ‘quasi‐random’. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias.</p> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation concealment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details concealed allocation sequence in sufficient detail to determine that allocations could not have been foreseen in advance of or during enrolment. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details a method where the allocation is known prior to assignment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Performance bias </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding of participants and personnel</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details a method of blinding the participants and personnel. This requires sufficient detail to show they were unable to identify the therapeutic intervention from the control intervention. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Considering the nature of the interventions, it may not be possible to blind the participants and therapists. The effect of this will be addressed in the Discussion. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Detection bias </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding of outcome assessment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details a blinded outcome assessment. This may only be possible for outcomes that are externally assessed. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the outcome assessment is not blinded. We expect this may be unavoidable for self rated outcomes of unblinded interventions. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias.</p> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Attrition bias</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incomplete outcome data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study reports attrition and exclusions, including the numbers in each intervention group (compared with total randomised participants), reasons for attrition or exclusions, and any re‐inclusions. Also, the impact of missing data is not believed to alter the conclusions, and there are acceptable reasons for the missing data. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We may judge the risk of attrition bias to be high due to the amount, nature, or handling (such as per‐protocol analysis) of incomplete outcome data. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias, e.g. if the number of people randomised to each treatment is not reported. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Reporting bias</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selective outcome reporting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is judged to be complete reporting, which will be found on comparison of the published study and protocol, if available. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the reporting is selective, so that some outcome data are not reported.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias, such as the protocol is not available. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Other sources of bias</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessment of other sources of bias in other domains not covered by the tool, including validity of outcome measures utilised </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is judged to be no other factors that would be likely to introduce major potential bias. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If other factors are identified that are judged to represent a high risk of bias.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of other bias.</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010972-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We reported our study results as follows.</p> <section id="CD010972-sec-0052"> <h5 class="title">Continuous data</h5> <p>For continuous data (e.g. pain intensity or frequency), we analysed means and standard deviations (SDs), where available or could be calculated, and providing there was no clear evidence of skew in the distribution. When different scales were used to measure the same clinical outcome, we combined standardised mean differences (SMDs) across the studies. We presented the pooled estimates with 95% confidence intervals (CIs). </p> </section> <section id="CD010972-sec-0053"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data (e.g. pain improved, yes or no), we analysed the data using odds ratios (ORs) and 95% CIs. </p> <p>The definition of pain improvement varied across the studies. We used the author definition of improvement. </p> </section> </section> <section id="CD010972-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <section id="CD010972-sec-0055"> <h5 class="title">Cross‐over trials</h5> <p>We considered the results of this type of trial using the guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010972-bbs2-0048" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>), in particular assessing whether an appropriate washout period was used. Given that RAP can be a stable and chronic condition, we considered a washout period of two to three weeks to be sufficient. </p> <p>Please see <a href="./appendices#CD010972-sec-0172">Appendix 2</a> and our protocol, <a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>, for additional methods for handling unit‐of‐analysis issues archived for use in future updates of this review. </p> </section> </section> <section id="CD010972-sec-0056"> <h4 class="title">Dealing with missing data</h4> <p>In the few cases where there were missing data, such as standard deviations, we contacted the original investigators to request if the missing data were available. When it was not possible to obtain the data from the original investigators, we did not impute values; this was a decision made a priori in our protocol (<a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>). Studies for which authors provided additional data not originally published are detailed in the <a href="./references#CD010972-sec-0182" title="">Characteristics of included studies</a>. </p> </section> <section id="CD010972-sec-0057"> <h4 class="title">Assessment of heterogeneity</h4> <p>We anticipated finding considerable heterogeneity among included studies. We assessed clinical heterogeneity by examining the distribution of relevant participant characteristics (e.g. age, definition of RAP) and study differences (e.g. concealment of randomisation, blinding of outcome assessors, interventions, or outcome measures). We described the statistical heterogeneity (observed variability in study results that is greater than that expected to occur by chance) by reporting the I² statistic (<a href="./references#CD010972-bbs2-0046" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [DOI: 10.1136/bmj.327.7414.557; PMC192859; PUBMED: 12958120] ">Higgins 2003</a>). The I² statistic describes approximately the proportion of variation in point estimates due to heterogeneity rather than sampling error. A value of more than 50% may indicate significant heterogeneity. We used the Chi² test to further assess the strength of evidence of the heterogeneity. We regarded any result with a P value lower than 0.10 as indicating significant statistical heterogeneity. We interpreted this cautiously and used it to help quantify the impact of heterogeneity on the results of the meta‐analysis and ultimately on the GRADE quality rating (see <a href="#CD010972-sec-0059">Data synthesis</a>). We also reported Tau² when using the random‐effects model (see <a href="#CD010972-sec-0179">Differences between protocol and review</a>), which provides an estimate of the between‐study variance (<a href="./references#CD010972-bbs2-0036" title="DeeksJJ , Higgins JPT. AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD010972-sec-0058"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not have more than 10 trials for each outcome, and so did not perform these analyses (see <a href="./appendices#CD010972-sec-0172">Appendix 2</a>; <a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>). </p> </section> <section id="CD010972-sec-0059"> <h4 class="title">Data synthesis</h4> <p>We used Review Manager 5 for statistical analysis (<a href="./references#CD010972-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collboration, 2014. ">Review Manager 2014</a>). Two review authors (TVN, AEM, RAA, AB, JTC) independently entered data into Review Manager 5 (<a href="./references#CD010972-bbs2-0071" title="The Nordic Cochrane Centre, The Cochrane Collboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collboration, 2014. ">Review Manager 2014</a>). </p> <p>We anticipated significant statistical and clinical heterogeneity. We reported summary statistics for continuous data as mean differences (MDs) or SMDs using a random‐effects model, weighted using the inverse‐variance method. For dichotomous data, we also used a random‐effects model and calculated the ORs using Mantel‐Haenszel methods, as this has been shown to have better statistical properties where event rates are low or study size small (<a href="./references#CD010972-bbs2-0036" title="DeeksJJ , Higgins JPT. AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> <p>We only conducted meta‐analyses if it was appropriate to do so, that is if the studies were sufficiently homogeneous. We thus only carried out a meta‐analysis using data from studies with equivalent dietary interventions. Where meta‐analysis was not appropriate, we provided a narrative description of the results. </p> <p>For all outcomes where we conducted a meta‐analysis, we produced a 'Summary of findings' table detailing the number of trials and participants, the results of the analysis, and the GRADE rating of quality of evidence for the outcome; the procedure for this is described below. </p> <section id="CD010972-sec-0060"> <h5 class="title">Assessing the quality of evidence for each outcome</h5> <p>We used the GRADE approach to assess the overall quality of the body of evidence for a specific outcome (<a href="./references#CD010972-bbs2-0089" title="SchünemannH , BrożekJ , GuyattG , OxmanA (editors) . GRADE Handbook: Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. The Grade Working Group, 2013 (update). ">The Grade Working Group 2013</a>). We used GRADEpro software to assess and present the findings in the 'Summary of findings' tables (<a href="./references#CD010972-bbs2-0042" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 12 December 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro GDT 2015</a>). We completed a 'Summary of findings' table for each main treatment comparison (<a href="./full#CD010972-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD010972-tbl-0002">summary of findings Table 2</a>). </p> <p>For the dichotomous outcome of pain improvement, we calculated the probable outcome of events per 1000 for both the control group and those receiving the intervention, following the guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010972-bbs2-0078" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011a</a>), similar to other reviews that include people with pain conditions (e.g. <a href="./references#CD010972-bbs2-0040" title="EcclestonC , PalermoT , WilliamsAC , Lewandowski HolleyA , MorleyS , FisherE , et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD003968.pub4] ">Eccleston 2014</a>). We judged the studies included for each outcome using five criteria: risk of bias, indirectness, inconsistency, imprecision, and publication bias. We used limitations in the design and implementation to assess the overall risk of bias of included studies for each outcome, downgrading an outcome if the majority of studies had unclear or high risk of bias. We assessed indirectness if a population, intervention, or outcome was not of direct interest to the review. Inconsistency was determined by the heterogeneity of results. If there was evidence of significant statistical heterogeneity (see <a href="#CD010972-sec-0057">Assessment of heterogeneity</a>), we downgraded the quality of the outcome. We assessed imprecision by the number of participants included in an outcome and by CIs; we downgraded outcomes when only a small number of participants could be included in the analysis or the analysis had wide CIs. Finally, we downgraded for publication bias if studies failed to report outcomes in the published manuscript or if there was a suspicion that null findings had not been published or reported (<a href="./references#CD010972-bbs2-0079" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011b</a>). </p> <p>We gave each outcome a quality rating ranging from 'very low' to 'high'. High‐quality ratings are given when "further research is unlikely to change our estimate of effect". Moderate‐quality ratings are given when "further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate". Low‐quality ratings are given when "further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate". Finally, very low‐quality ratings are given when "we are very uncertain about the estimate" (<a href="./references#CD010972-bbs2-0032" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. [DOI: 10.1016/j.jclinepi.2010.07.015; PUBMED: 21208779] ">Balshem 2011</a>). </p> </section> </section> <section id="CD010972-sec-0061"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where data were available, we carried out subgroup analyses by subtype of RAP and by duration of follow‐up, as specified in our protocol (<a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>). </p> </section> <section id="CD010972-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>In our protocol we planned to carry out sensitivity analyses to assess the robustness of our conclusions in relation to two aspects of study design (<a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>). We intended to assess: 1) the effect of inadequate allocation concealment, and 2) the effect of inadequate blinding to treatment, by removal of studies judged to be at high or unclear risk of bias in these domains. We performed sensitivity analyses where pooled analyses included such studies. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010972-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010972-sec-0063"></div> <section id="CD010972-sec-0064"> <h3 class="title">Description of studies</h3> <p>For a full description of the main characteristics of the studies, including details on participants and setting, intervention aspects, and outcome measures, see: <a href="./references#CD010972-sec-0182" title="">Characteristics of included studies</a>; <a href="./references#CD010972-sec-0183" title="">Characteristics of excluded studies</a>; <a href="./references#CD010972-sec-0184" title="">Characteristics of studies awaiting classification</a>. </p> <section id="CD010972-sec-0065"> <h4 class="title">Results of the search</h4> <p>For this updated review, we chose to redesign the search strategy in order to include the recognised terms for different types of RAP, as defined by the Rome criteria (<a href="./references#CD010972-bbs2-0070" title="RasquinA , DiLorenzoC , ForbesD , GuiraldesE , HyamsJS , StaianoA , et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology2006;130(5):1527–37. [DOI: 10.1053/j.gastro.2005.08.063; PUBMED: 16678566] ">Rasquin 2006</a>). Consequently, we ran our searches across the databases with no date restriction. The results of the searching and screening are shown in the PRISMA flow chart (<a href="#CD010972-fig-0001">Figure 1</a>). We screened a total of 9649 titles and abstracts, of which 231 were carried forward for further screening at full text. We excluded 203 reports at full text and included 27 reports (19 studies) in the review. One study is awaiting classification (<a href="./references#CD010972-bbs2-0026" title="Jarocka‐CyrtaE , UscinowiczM , WasilewskaJ , KaczmarskiM . The role of cow's milk allergy in recurrent abdominal pain in children above 6 years of age. Double‐blind placebo controlled food challenge. Journal of Pediatric Gastroenterology and Nutrition2002;34(4):458. ">Jarocka‐Cyrta 2002</a>). </p> <div class="figure" id="CD010972-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram" data-id="CD010972-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram</p> </div> </div> </div> </section> <section id="CD010972-sec-0066"> <h4 class="title">Included studies</h4> <p>We included 19 studies in this review, which were reported in 27 papers, four of which were included in the previous version of our review (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). Two of the included studies were only reported as abstracts, and we were unable to obtain further details of the methods or results; either we could not contact the authors of the studies or the authors were unable to provide the details requested (<a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). However, based on the data in the abstracts, the studies met the inclusion criteria (<a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> <p>Thirteen studies were trials of probiotic‐based interventions (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>), and four studies were trials of fibre‐based interventions (<a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>). One study was a trial of a low FODMAP diet (<a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>), and one was a trial of a fructose‐restricted diet (<a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>). All included studies were written in English. We contacted the authors of <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a> and <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>, and they provided raw data for pain frequency and intensity outcomes, as these were not included in the published paper. The authors of <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a> also provided additional data. For more information, please see below and the <a href="./references#CD010972-sec-0182" title="">Characteristics of included studies</a> tables. </p> <section id="CD010972-sec-0067"> <h5 class="title">Participants</h5> <p>The 19 included studies involved a total of 1453 children. Thirteen studies, with a total of 1017 children, investigated the effects of probiotics versus placebo (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). Four studies, with a total of 299 children, investigated the effects of fibre‐based interventions versus placebo (<a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>). The single study of the FODMAP diet versus typical diet included 34 children (<a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>), and the trial of a fructose‐restricted diet included 103 children (<a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>). Eleven included trials randomised between 50 and 90 children; the smallest study included only 11 children (<a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>), and the six largest more than 100 each (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>; <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>). Participants were aged between four and 18 years, with the mean age at recruitment ranging from 6.3 years to 13.1 years. Girls outnumbered boys in most included trials. Fourteen trials recruited children with a diagnosis under the broad umbrella of RAP or functional gastrointestinal disorders; five trials specifically recruited only children with irritable bowel syndrome (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>). In <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>, children were only randomised if they first failed to respond to an eight‐day exclusion diet eliminating carbohydrates (defined as 75% or less improvement in abdominal pain frequency and severity). </p> </section> <section id="CD010972-sec-0068"> <h5 class="title">Settings</h5> <p>The majority of studies took place in paediatric gastroenterology clinics. In <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>, children were recruited from primary care paediatric practices, and in <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> children came from private general practice practices and community paediatric clinics. Children in <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a> and <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a> came from care networks, including both primary and tertiary care. <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a> advertised for participants from community settings as well as recruiting from paediatric gastroenterology clinics. </p> </section> <section id="CD010972-sec-0069"> <h5 class="title">Location</h5> <p>Trials took place across eight countries. Six studies were conducted in Italy (<a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>), four in Iran (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>), four in the USA (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>), two in Poland (<a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>), and one each in Canada (<a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>), Israel (<a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>), Germany (<a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>), and India (<a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>). </p> </section> <section id="CD010972-sec-0070"> <h5 class="title">Interventions</h5> <p>We classified interventions into four groups: probiotic‐based interventions, fibre‐based interventions, low FODMAP‐based diet interventions, and fructose‐restricted diets. We did not include peppermint oil as a dietary intervention but categorised it as pharmacological; trials of this intervention are therefore considered in the companion pharmacological review (<a href="./references#CD010972-bbs2-0060" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , WhearR , et al. Pharmacological interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD010973.pub2] ">Martin 2014a</a>). </p> <section id="CD010972-sec-0071"> <h6 class="title">Probiotic interventions</h6> <p>Thirteen trials used probiotic‐based interventions. Not all trials assessed the same probiotic‐based intervention. Five trials used <i>Lactobacillus rhamnosus</i> GG in slightly different preparations (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>). Three other trials used <i>Lactobacillus reuteri</i> (<a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>). The probiotic in <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a> was <i>Lactobacillus plantarum</i> (LP299V). <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a> was a cross‐over trial where the intervention was VSL#3, a probiotic preparation of different strains. <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a> was a cross‐over trial using a mixture of three <i>Bifidobacterium</i> species<i>.</i><a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a> and <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a> used <i>Bacillus coagulans</i> plus fructo‐oligosaccharides. The treatment period ranged from four weeks, in <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>, <a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>, <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>, <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>, <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>, <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>, <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>, and <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>, to eight weeks, in <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>. In most studies, outcomes were measured immediately postintervention; the longest period of follow‐up was 16 weeks, in <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>. Only two studies measured outcomes at three to 12 months' postintervention (<a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>). </p> </section> <section id="CD010972-sec-0072"> <h6 class="title">Fibre interventions</h6> <p>Four trials used fibre‐based interventions. These included a fibre biscuit containing 5 g of corn fibre (<a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>), a preparation of partially hydrolysed guar gum (PHGG) (<a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>), a preparation of glucomannan (GNN) (<a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>), and psyllium fibre (<a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>). The treatment period ranged from four weeks, in <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a> and <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>, to six weeks, in <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> and <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>. Three of the studies measured outcomes immediately postintervention (<a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>), and the fourth measured outcomes immediately postintervention and four weeks afterwards (<a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>). </p> </section> <section id="CD010972-sec-0073"> <h6 class="title">Low FODMAP interventions</h6> <p>Only one included trial examined a low FODMAP diet intervention. <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a> was a cross‐over trial comparing a two‐day low FODMAP diet intervention with a control of a typical American childhood diet (TACD). Outcomes were measured immediately after intervention at two days. We found no other RCTs of low FODMAP diets. </p> </section> <section id="CD010972-sec-0074"> <h6 class="title">Fructose‐restricted diets</h6> <p>We found one trial of a fructose‐restricted diet (<a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>), where participants with RAP for more than three months were randomised to a specified low‐fructose diet or a standard diet for two weeks, with outcomes measured immediately postintervention. We found no other eligible RCTs of this type of intervention. </p> </section> </section> <section id="CD010972-sec-0075"> <h5 class="title">Comparators</h5> <p>All included trials assessed the dietary intervention against a placebo comparison, with the exception of <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a> and <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>, where the comparator was a standard diet. <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a> was a three‐arm trial where probiotics were compared against peppermint oil and placebo; however, only the probiotics versus placebo comparison was reported in this review. </p> </section> <section id="CD010972-sec-0076"> <h5 class="title">Outcomes</h5> <p>The primary outcomes of this review related to abdominal pain, and pain outcomes were reported in every trial. Studies reported on pain in terms of pain improvement (usually defined as a percentage or number of points improved from baseline, or being pain‐free), pain severity/intensity, or pain frequency; or a combination of all three. Pain was most commonly assessed using versions of the Faces Pain Scale (<a href="./references#CD010972-bbs2-0034" title="BieriD , ReeveR , ChampionGD , AddicoatL , ZieglerJ . The Faces Pain Scale for the self‐assessment of the severity of pain experienced by children: development, initial validation and preliminary investigation for ratio scale properties. Pain1990;41:139‐50. [PUBMED: 2367140] ">Bieri 1990</a>; <a href="./references#CD010972-bbs2-0061" title="McGrathPA , SeifertCE , SpeechleyKN , BoothJC , StittL , GibsonMC . A new analogue scale for assessing children's pain: an initial validation study. Pain1996;64(3):435‐43. [PUBMED: 8783307] ">McGrath 1996</a>; <a href="./references#CD010972-bbs2-0097" title="WongD , BakerC . Pain in children: comparison of assessment scales. Pediatric Nursing1988;14(1):9‐17. [PUBMED: 3344163] ">Wong 1988</a>), or by using a standard visual analogue scale, typically with a range of 0 to 10. Other studies used more general measures to assess improvement in symptoms, including pain, such as the Subject's Global Assessment of Relief Child version (SGARC) (<a href="./references#CD010972-bbs2-0063" title="Müller‐LissnerS , KochG , TalleyNJ , DrossmanD , RueeggP , Dunger‐BaldaufC , et al. Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome‐related symptoms in clinical trials. Journal of Clinical Epidemiology2003;56(4):310‐6. [PUBMED: 12767407] ">Muller‐Lissner 2003</a>). A number of studies specified that the outcome was child reported (<a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>). In other studies it was not specified whether the parent or child was completing the measure, or it was stated that pain was reported by "child or family/parent". As the age range in most studies was wide, this is likely to have influenced who was reporting on the measures. Authors usually reported that pain was assessed on a daily basis (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>; <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>). <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a> reported that symptoms were recorded at the end of the intervention. In the remaining studies the frequency of measure completion was not clearly described. </p> <p>Secondary outcomes included in this review were school performance, social or psychological functioning, and quality of daily life. Not all studies measured these outcomes. <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>, <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>, and <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a> reported on school absenteeism, and <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a> and <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a> reported on disruption of daily activities. Participants in <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a> reported on both absence from school and disruption of social activities as part of functional changes on a three‐point Likert scale. In <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>, participants completed the Functional Disability Inventory (<a href="./references#CD010972-bbs2-0035" title="ClaarRL , WalkerLS . Functional assessment of pediatric pain patients: psychometric properties of the functional disability inventory. Pain2006;121(1‐2):77‐84. [DOI: 10.1016/j.pain.2005.12.002; PMC3144698; PUBMED: 16480823] ">Claar 2006</a>), which assesses physical and psychosocial functions and quality of life. In <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>, participants completed Paediatric Quality of Life Generic Core Scales (<a href="./references#CD010972-bbs2-0091" title="VarniJW , BendoCB , DenhamJ , ShulmanRJ , SelfMM , NeigutDA , et al. PedsQL Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls. Quality of Life Research2015;24(2):363–78. [DOI: 10.1007/s11136‐014‐0781‐x; PUBMED: 25148757] ">Varni 2015</a>). </p> </section> <section id="CD010972-sec-0077"> <h5 class="title">Adverse events</h5> <p>All studies except <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> and <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a> reported that they monitored children for adverse events. This information was not available in the two included abstracts, and the authors either did not respond to requests for further information (<a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>), or they were unable to provide details (<a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> </section> <section id="CD010972-sec-0078"> <h5 class="title">Funding</h5> <p>Ten studies did not report their source of funding (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>; <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). Four studies reported being funded by their university (<a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>); one was funded by "locally available grants", although the intervention and placebo were provided by industry (<a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>), and one study was funded by a university seed grant (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>). <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a> was funded by various organisations, including the US National Institutes of Health and the US Department of Agriculture. <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a> was funded by an academic society in conjunction with Nestlé and the National Institutes of Health. </p> </section> </section> <section id="CD010972-sec-0079"> <h4 class="title">Excluded studies</h4> <p>The PRISMA diagram (<a href="#CD010972-fig-0001">Figure 1</a>) outlines the number of studies excluded at the full‐text screening stage (n = 231). The majority of these clearly involved an ineligible population (e.g. adults) or ineligible interventions (psychosocial or pharmacological), and therefore we have not listed or described these further. However, we excluded six studies for less obvious reasons, and have described these here and listed them in the <a href="./references#CD010972-sec-0183" title="">Characteristics of excluded studies</a> section. </p> <p>We excluded three studies that were included in the 2009 review, <a href="./references#CD010972-bbs2-0100" title="Huertas‐CeballosA , LoganS , BennettC , MacarthurC . Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3] ">Huertas‐Ceballos 2009</a>, on the grounds of study design (<a href="./references#CD010972-bbs2-0021" title="ChristensenMF . Do bulk preparations help in cases of recurrent abdominal pain in children? A controlled study [Hjaelper fyld praeparater pa recidiverende mavesmerter hos born? En kontrolleret study]. Ugeskrift for Laeger1982;144(10):714‐5. [PUBMED: 7048679] ">Christensen 1982</a>; <a href="./references#CD010972-bbs2-0023" title="DearloveJ , DearloveB , PearlK , ParmavesiR . Dietary lactose and the child with abdominal pain. British Medical Journal1983;286(6382):1936. [DOI: PMC1548276; PUBMED: 6407644] ">Dearlove 1983</a>; <a href="./references#CD010972-bbs2-0025" title="LebenthalE , RossiTM , NordKS , BranskiD . Recurrrent abdominal pain and lactose absorption in children. Pediatrics1981;67(6):828‐32. [PUBMED: 7195004] ">Lebenthal 1981</a>). <a href="./references#CD010972-bbs2-0021" title="ChristensenMF . Do bulk preparations help in cases of recurrent abdominal pain in children? A controlled study [Hjaelper fyld praeparater pa recidiverende mavesmerter hos born? En kontrolleret study]. Ugeskrift for Laeger1982;144(10):714‐5. [PUBMED: 7048679] ">Christensen 1982</a> and <a href="./references#CD010972-bbs2-0023" title="DearloveJ , DearloveB , PearlK , ParmavesiR . Dietary lactose and the child with abdominal pain. British Medical Journal1983;286(6382):1936. [DOI: PMC1548276; PUBMED: 6407644] ">Dearlove 1983</a> did not appear to be RCTs. It was also unclear whether participants in <a href="./references#CD010972-bbs2-0025" title="LebenthalE , RossiTM , NordKS , BranskiD . Recurrrent abdominal pain and lactose absorption in children. Pediatrics1981;67(6):828‐32. [PUBMED: 7195004] ">Lebenthal 1981</a> were randomised, and as we were unable to clarify this with the authors, we also excluded this study. </p> <p>From our updated search in 2016, we excluded one study that was not a RCT (<a href="./references#CD010972-bbs2-0020" title="AgahS , TalebA , MoeiniR , GorjiN , NikbakhtH , Soltani‐KermanshahiM . Chamomile efficacy in patients of the irritable bowel syndrome. Der Pharma Chemica2015;7(4):237‐41. ">Agah 2015</a>). We excluded two further studies because they used ineligible comparators (<a href="./references#CD010972-bbs2-0022" title="ChumpitaziBP , TsaiCM , McMeansAR , ShulmanRJ . A low FODMAPS diet ameliorates symptoms in children with irritable bowel syndrome: a double blind, randomized crossover trial. Gastroenterology2014;146(5 Suppl 1):S‐144. [DOI: 10.1016/S0016‐5085(14)60511‐4] ">Chumpitazi 2014</a>; <a href="./references#CD010972-bbs2-0024" title="EdwardsMC , FinneyJW , BonnerM . Matching treatment with recurrent abdominal pain symptoms: an evaluation of dietary fiber and relaxation treatments. Behavior Therapy1991;22(2):257‐67. [DOI: 10.1016/S0005‐7894(05)80181‐9] ">Edwards 1991</a>). </p> </section> </section> <section id="CD010972-sec-0080"> <h3 class="title">Risk of bias in included studies</h3> <p>We rated all included studies for risk of bias across the following categories: random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias) and other potential sources of bias (other bias). <a href="#CD010972-fig-0002">Figure 2</a> displays the review authors' assessments of risk of bias for each study individually, and <a href="#CD010972-fig-0003">Figure 3</a> represents the authors' judgements about each risk of bias item presented as percentages across all included studies. </p> <div class="figure" id="CD010972-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010972-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD010972-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010972-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010972-sec-0081"> <h4 class="title">Allocation</h4> <p>We rated no studies as being at high risk of bias in this domain.</p> <section id="CD010972-sec-0082"> <h5 class="title">Random sequence generation</h5> <p>We judged that the majority of studies had adequately randomised their participants as they used appropriate methods of randomisation as detailed in <a href="#CD010972-tbl-0003">Table 1</a>, such as computer‐generated random numbers. The exceptions were <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>, <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>, and <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>, all of which we rated as being at unclear risk in this domain due to insufficient detail provided about how randomisation was performed. We also rated the two studies for which only abstracts were available as at unclear risk of bias in this domain due to insufficient detail provided about randomisation (<a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> </section> <section id="CD010972-sec-0083"> <h5 class="title">Allocation concealment</h5> <p>The most frequently encountered issue in assessing the risk of selection bias was poorly described allocation sequence concealment. The authors of seven studies provided insufficient detail on how this was done, leading to an assessment of unclear risk of bias (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> </section> </section> <section id="CD010972-sec-0084"> <h4 class="title">Blinding</h4> <section id="CD010972-sec-0085"> <h5 class="title">Blinding of participants and personnel</h5> <p>Most studies described the use of identical placebos and double‐blinding of participants and personnel, and so we judged them to be at low risk of performance bias. However, we rated <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a> as being at unclear risk of bias for this outcome, as although the study was blinded, the placebo regimen of folic acid tablets was different in timing and frequency to the intervention regimen, and the authors did not discuss the possible impact of this. In <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>, the study was described as double‐blinded, but it was unclear whether the intervention and control diets were delivered in identical containers or what clues there might have been to the allocation, hence we also rated this study as being at unclear risk of bias. We rated one study as being at high risk of bias for this domain, as the children who rated their own symptoms were not blinded (<a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>). </p> </section> <section id="CD010972-sec-0086"> <h5 class="title">Blinding of outcome assessment</h5> <p>Outcomes were assessed by parents, children, and clinicians; the issues described above regarding blinding of participants and personnel also applied to the blinding of outcome assessment, consequently we rated all studies as being at low risk of bias for this domain with the exception of <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>, <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a>, <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>, and <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>. </p> </section> </section> <section id="CD010972-sec-0087"> <h4 class="title">Incomplete outcome data</h4> <p>We rated 10 studies as being at unclear risk of attrition bias; many studies did not fully report outcome data, making it difficult to assess the risk of attrition bias (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>; <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). For example, in <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>, 32 children were excluded during the trial after randomisation and not analysed because they did not complete the one‐month intervention; according to the authors this was "due to journey or lack of 2 weeks visit", but information was insufficient to determine if this could have resulted in attrition bias. Also, in <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>, the authors state that an intention‐to‐treat analysis was carried out, but the paper also states that eight participants were excluded due to "poor compliance and violation of the protocol" and not analysed, hence the exact methodology was unclear. Again, for the two studies for which only abstracts were available, insufficient detail was provided, so they too were rated as being unclear risk of bias for this domain (<a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> </section> <section id="CD010972-sec-0088"> <h4 class="title">Selective reporting</h4> <p>We did not rate any studies as being at high risk of bias for this domain. <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> presented insufficient information to assess reporting bias and so was judged to be at unclear risk of bias. We also judged <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a> to be at unclear risk of reporting bias as comparisons were made pre/post and not between intervention and control at six weeks. Again, for the two studies for which only abstracts were available, insufficient detail was provided, so they too were rated as being unclear risk of bias for this domain (<a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> </section> <section id="CD010972-sec-0089"> <h4 class="title">Other potential sources of bias</h4> <p>We rated the risk of other potential biases (such as validity of data collection tools, appropriate sample size, similarity of baseline details) as low for included studies for which we had the full text, as we did not find any other major sources of bias that would likely affect the results. The exceptions were <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>, which we rated at high risk of bias as there were imbalances in measures of pain at baseline; <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>, which we rated as being at unclear risk of bias as no details were given regarding the use of validated tools or of adherence; and <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a> and <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>, which we also rated at unclear risk of bias due to insufficient information in the abstracts. </p> </section> </section> <section id="CD010972-sec-0090"> <h3 class="title" id="CD010972-sec-0090">Effects of interventions</h3> <p>See: <a href="./full#CD010972-tbl-0001"><b>Summary of findings for the main comparison</b> Probiotics compared to placebo for recurrent abdominal pain in childhood</a>; <a href="./full#CD010972-tbl-0002"><b>Summary of findings 2</b> Fibre versus placebo for recurrent abdominal pain in childhood</a> </p> <p>We were able to perform a total of 10 analyses across the studies. We performed analyses within intervention type, as the mechanisms of action of each dietary intervention are different. We only performed analyses on those studies that provided equivalent outcome data in comparable formats, therefore not all studies within each intervention type were entered into the analyses. </p> <p>For probiotic‐based interventions, we were able to perform three analyses for our primary outcomes (effects on pain frequency, pain intensity, and pain improvement), at zero to three months' postintervention. As four studies included only children with irritable bowel syndrome, or reported outcomes for this group separately, as per our protocol (<a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>), we were also able to perform a subgroup analysis for this group for the outcome of improvement in pain at zero to three months' postintervention. We were able to perform one analysis for the outcome of improvement in pain at three to six months' postintervention. We also were able to perform sensitivity analyses for three outcomes, by removing studies judged to be at unclear or high risk of bias in the domains of allocation concealment, blinding of participants and personnel, and/or blinding of outcome assessment. </p> <p>For fibre‐based interventions, we were able to perform two analyses: effect on pain improvement and change in pain intensity postintervention (zero to three months). </p> <p>We were unable to perform any analyses for low FODMAP diet interventions or for fructose‐restricted diets, as we found only one study in each category eligible for inclusion. </p> <p>We were unable to perform any pooled analyses of secondary outcomes for any dietary intervention, as these were either not reported or reported in formats that were not comparable. The results of individual studies are briefly presented below, followed by the results of the pooled analyses. </p> <p>We assessed the quality of evidence using the GRADE criteria (<a href="./references#CD010972-bbs2-0089" title="SchünemannH , BrożekJ , GuyattG , OxmanA (editors) . GRADE Handbook: Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. The Grade Working Group, 2013 (update). ">The Grade Working Group 2013</a>), and presented our ratings in 'Summary of findings' tables, which we constructed using GRADEpro software (<a href="./references#CD010972-bbs2-0042" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 12 December 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014. ">GRADEpro GDT 2015</a>). Within probiotic‐based interventions, we scored the evidence for the three improvement in pain outcomes as moderate quality, meaning that further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. For the change in pain intensity and frequency outcomes, we rated the evidence as low quality, meaning that future research is likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. See <a href="./full#CD010972-tbl-0001">summary of findings Table for the main comparison</a>. For fibre‐based interventions, we rated the evidence for the change in pain intensity and improvement in pain outcomes as low quality. See <a href="./full#CD010972-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD010972-sec-0091"> <h4 class="title">Comparison 1: Probiotic interventions versus placebo</h4> <p>Thirteen included studies assessed the effects of probiotics (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>; <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a>). </p> <section id="CD010972-sec-0092"> <h5 class="title">Primary outcomes</h5> <section id="CD010972-sec-0093"> <h6 class="title">Results of individual studies</h6> <p>Here, we briefly present the results of the individual studies (please note, we could only provide exact P values when these were available in the original report). </p> <section id="CD010972-sec-0094"> <p><b>Change in pain frequency, change in pain intensity, and improvement in pain</b></p> <p><a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a> reported on pain severity, duration, and frequency immediately following a four‐week intervention with <i>Bacillus coagulans</i> plus fructo‐oligosaccharides. Mean decrease in pain duration and pain frequency was greater in the probiotic group compared to the placebo group (P = 0.012 and P &lt; 0.001, respectively). </p> <p><a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a> reported no difference between the probiotic arm and placebo arm in response to treatment, defined as improvement in abdominal pain of one or more levels, at six weeks (OR 1.18, 95% CI 0.38 to 3.63). There was also no difference between the two groups in terms of mean change in pain (P = 0.175) as measured by the Gastrointestinal Symptoms Rating Scale (<a href="./references#CD010972-bbs2-0087" title="SvedlundJ , SjödinI , DotevallG . GSRS ‐ a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive Diseases and Sciences1988;33(2):129‐34. [PUBMED: 3123181] ">Svedlund 1988</a>). </p> <p><a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a> reported no significant difference in pain intensity, pain frequency, or improvement in pain between probiotic and placebo arms at four and eight weeks' postintervention. At both time points, pain intensity and severity in both groups were significantly reduced from baseline (P &lt; 0.001). </p> <p><a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a> reported results at eight and 16 weeks' postintervention. At eight weeks, treatment success was experienced by 72% of children in the probiotic group and 53% of children in the placebo group (OR 2.18, 95% CI 1.07 to 4.45), and the difference was maintained at 16 weeks (79% intervention, 62% control; P &lt; 0.03). Pain intensity was lower in the intervention group at eight weeks (P &lt; 0.01), and pain frequency was reduced at eight weeks (P &lt; 0.01) and 12 weeks (P &lt; 0.02). </p> <p><a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a> reported that at four weeks, 25% of the intervention group experienced treatment success in terms of no pain compared to 9.6% of the placebo group (OR 3.1, 95% CI 1.03 to 9.56). Overall, 25 children receiving probiotics experienced improvement in pain compared to 23 receiving placebo (OR 1.17, 95% CI 0.62 to 2.21). No other significant differences in outcome measure were reported, including change in pain frequency and intensity. </p> <p><a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a> reported only pre/post comparisons on change in pain frequency and intensity at week six, and we could obtain no additional information for these outcomes to enter in the meta‐analysis. At six weeks, 44 of 59 children experienced an improvement in pain in the intervention arm of the cross‐over, compared to 29 children in the placebo group (OR 3.03, 95% CI 1.4 to 6.6). </p> <p><a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a> was a cross‐over RCT with a six‐week treatment period and a two‐week washout period. The primary outcome was being pain‐free at six weeks. In children with irritable bowel syndrome, 42% experienced full resolution on probiotic versus 14% on placebo (P = 0.003); in those with functional dyspepsia there was no improvement (21% versus 32%; P = 0.5). </p> <p><a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a> measured pain severity at four weeks; the mean score in the probiotic group was significantly lower than the mean score in the placebo group at this time point (P &lt; 0.001). </p> <p>In <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>, the intervention group experienced a significant decrease in pain intensity at eight weeks (P &lt; 0.001), and both groups had a decrease in pain frequency at the same time point (P &lt; 0.05). </p> <p><a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a> reported outcomes at six and 10 weeks. In the probiotic group, there was a significant reduction of both frequency (P &lt; 0.01) and severity (P &lt; 0.01) of abdominal pain at six weeks. These differences were still present at 10‐week follow‐up (P &lt; 0.02 and P &lt; 0.001, respectively). </p> <p>In <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>, a higher proportion of children in the intervention group (60%) compared to the control group (39.5%) were defined as treatment responders at four weeks (P = 0.044), but this difference was not sustained at 12 weeks (64.4% intervention, 53.4% control; P = 0.204). The authors reported no statistically significant difference between intervention and control in terms of physician‐rated global pain severity or global improvement. </p> <p>In <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>, pain intensity was significantly reduced in the intervention group compared to the placebo group at four weeks (P &lt; 0.01) and eight weeks (P &lt; 0.02); the difference in pain frequency was significant at four weeks (P &lt; 0.02) but was not sustained at eight weeks (P = 0.09). </p> <p><a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a> was a cross‐over RCT. In the abstract the authors report that children treated with probiotic had a significant reduction in symptoms at four weeks when compared to baseline, whereas placebo treatment did not produce significant improvement. </p> </section> </section> <section id="CD010972-sec-0095"> <h6 class="title">Results of pooled analyses</h6> <p>See <a href="./full#CD010972-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD010972-sec-0096"> <p><b>Change in pain frequency</b></p> <p>We pooled data from six studies at zero to three months' postintervention in a meta‐analysis to examine change in pain frequency (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>). The SMD of effect across the studies was ‐0.55 (95% CI ‐0.98 to ‐0.12; Z = 2.52; P = 0.01; 523 children; <a href="./references#CD010972-fig-0006" title="">Analysis 1.1</a>). However, there was significant statistical heterogeneity (Tau² = 0.23; Chi² = 28.10; I² = 82%; P for heterogeneity &lt; 0.001). Using GRADE, we rated the quality of evidence for this outcome as low, downgrading it two levels due to risk of bias in the included studies and the statistical heterogeneity. For our planned sensitivity analysis, we identified two included studies where there was an unclear risk of bias in relation to allocation concealment or blinding of participants and personnel and/or blinding of outcome assessment (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>), and repeated the pooled analysis after excluding these two studies. The estimate of effect was a SMD of ‐0.54 (95% CI ‐0.94 to ‐0.14; Z = 2.62; P = 0.009; 4 studies; 389 children; Tau² = 0.12; Chi² = 11.24; I² = 73%; P for heterogeneity = 0.01; <a href="./references#CD010972-fig-0007" title="">Analysis 1.2</a>). Removing these studies therefore did not appreciably change the estimate of effect from the main analysis in <a href="./references#CD010972-fig-0006" title="">Analysis 1.1</a>. </p> </section> <section id="CD010972-sec-0097"> <p><b>Change in pain intensity</b></p> <p>We entered data from seven studies into the meta‐analysis of change in pain intensity (<a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a>; <a href="./references#CD010972-bbs2-0012" title="RomanoC . Systematic review [personal communication]. Email to: Dr R Abbott (RAP review team, University of Exeter, UK) 25 April 2014. RomanoC , FerraùV , CavataioF , IaconoG , SpinaM , LionettiE , et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health 2010 Jul 8 [epub ahead of print]:1‐4. [DOI: 10.1111/j.1440‐1754.2010.01797.x; PUBMED: 20626584] ">Romano 2010</a>; <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>). The SMD of effect across the studies was ‐0.50, (95% CI ‐0.85 to ‐0.15; Z = 2.80; P = 0.005; 575 children; <a href="./references#CD010972-fig-0008" title="">Analysis 1.3</a>), and again there was considerable statistical heterogeneity (Tau² = 0.17; Chi² = 24.95; I² = 76%; P for heterogeneity &lt; 0.001). Using GRADE, we rated the quality of evidence for this outcome as low, downgrading it two levels due to risk of bias in the included studies and the statistical heterogeneity. We were able to perform a sensitivity analysis (again excluding <a href="./references#CD010972-bbs2-0001" title="AsgarshiraziM . Study information [personal communication]. Email to: A Martin 1 November 2016. AsgarshiraziM , ShariatM , DaliliH . Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + Fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study. Iranian Red Crescent Medical Journal2015;17(4):e23844. [DOI: 10.5812/ircmj.17(4)2015.23844; PMC4443394; PUBMED: 26023339] ">Asgarshirazi 2015</a> and <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>). The estimate of effect in the sensitivity analysis was a SMD of ‐0.68 (95% CI ‐1.05 to ‐0.30; P = 0.001; 5 studies; 441 children; Tau² = 0.13; Chi² = 14.00; I² = 71%; P for heterogeneity = 0.007; <a href="./references#CD010972-fig-0009" title="">Analysis 1.4</a>). Again, this did not result in appreciable change to the estimate of effect from the main analysis in <a href="./references#CD010972-fig-0008" title="">Analysis 1.3</a>. </p> </section> <section id="CD010972-sec-0098"> <p><b>Improvement in pain</b></p> <p>Seven studies (722 children) were eligible for meta‐analysis for the outcome of improvement in pain (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>). The OR for pain improvement at zero to three months' postintervention was 1.63 (95% CI 1.07 to 2.47; Z = 2.27; P = 0.02; Tau² = 0.14; Chi² = 10.98; I² = 45%; P for heterogeneity = 0.09; <a href="./references#CD010972-fig-0010" title="">Analysis 1.5</a>), with eight as the number needed to treat for an additional beneficial outcome (NNTB) (see <a href="#CD010972-fig-0004">Figure 4</a>). Using GRADE, we rated the quality of the evidence for this outcome as moderate, downgrading it one level due to evidence of statistical heterogeneity. In this analysis, the heterogeneity appeared to have been introduced by one of the new studies in the update search (<a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a>); prior to its inclusion in the pooled analysis there was no significant evidence of statistical heterogeneity (Tau² = 0.00; I² = 0%; P for heterogeneity = 0.41). On examination of the forest plot (see <a href="#CD010972-fig-0004">Figure 4</a>), <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a> was also the only study where the point estimate of effect favours placebo rather than probiotic (OR 0.54, 95% CI 0.22 to 1.32). We carried out a planned sensitivity analysis by removing <a href="./references#CD010972-bbs2-0004" title="EftekhariK , VahediZ , Kamali AghdamM , Noemi DiazD . A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iranian Journal of Pediatrics2015;25(6):e2616. [DOI: 10.5812/ijp.2616; PMC4662837] ">Eftekhari 2015</a> from the pooled analysis due to our judgement on the risk of bias present in this study. The resulting estimate of effect was an OR of 1.95 (95% CI 1.40 to 2.70; Z = 3.97; P &lt; 0.001; 6 studies; 642 children; Tau² = 0.00; Chi² = 3.96; I² = 0%; P for heterogeneity = 0.56; <a href="./references#CD010972-fig-0011" title="">Analysis 1.6</a>). </p> <div class="figure" id="CD010972-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Probiotics versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention." data-id="CD010972-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Probiotics versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention. </p> </div> </div> </div> <p>We were able to perform one subgroup analysis of improvement in pain at zero to three months' postintervention for 344 children with irritable bowel syndrome only (<a href="./references#CD010972-fig-0012" title="">Analysis 1.7</a>). This included four studies (<a href="./references#CD010972-bbs2-0002" title="BaussermanM , MichailS . The use of Lactobacillus GG in irritable bowel syndrome in children: a double blind randomized control trial. Journal of Pediatrics2005;147(2):197‐201. [DOI: 10.1016/j.jpeds.2005.05.015] ">Bausserman 2005</a>; <a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a>; <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>). The OR for pain improvement at zero to three months' postintervention was 3.01 (95% CI 1.77 to 5.13; Z = 4.06; P &lt; 0.001; Tau² = 0.06; Chi² = 3.77; I² = 21%; P for heterogeneity = 0.29), with a NNTB of four. Using GRADE, we rated the quality of the evidence for this outcome as moderate, downgrading it one level for imprecision, due to small numbers of participants in included studies. </p> <p>Only two studies (224 children) were eligible for inclusion in an analysis of improvement in pain at three to six months' postintervention (<a href="./references#CD010972-bbs2-0006" title="FrancavillaR , MagistàAM , LionettiE , DeCanioA , CastellanetaS , CavalloL . Lactobacillus GG in children with chronic abdominal pain: a double‐blind placebo‐controlled control trial. Digestive and Liver Disease2009;41 Suppl 3:s217. [DOI: 10.1016/S1590‐8658(09)60493‐X] FrancavillaR , MinielloV , MagistàAM , DeCanioA , BucciN , GagliardiF , et al. A randomised controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics2010;126(6):1445‐51. [PUBMED: 21078735] RoseMA . Lactobacillus rhamnosus GG reduces frequency and severity of abdominal pain compared with placebo in children with irritable bowel syndrome. Evidence Based Medicine2011;16(5):141‐2. [DOI: 10.1136/ebm1199; PUBMED: 21460397] ">Francavilla 2010</a>; <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>), as most studies had short follow‐up periods. The OR for pain improvement at three to six months' postintervention was 1.94 (95% CI 1.10 to 3.43; Z = 2.28; P = 0.02; Tau² = 0.00; Chi² = 0.41; I² = 0%; P for heterogeneity = 0.52; <a href="./references#CD010972-fig-0013" title="">Analysis 1.8</a>), with a NNTB of seven. Using GRADE, we rated the quality of the evidence for this outcome as moderate, downgrading it one level due to imprecision. </p> </section> </section> </section> <section id="CD010972-sec-0099"> <h5 class="title">Secondary outcomes</h5> <section id="CD010972-sec-0100"> <h6 class="title">Results of individual studies</h6> <section id="CD010972-sec-0101"> <p><b>School performance</b></p> <p><a href="./references#CD010972-bbs2-0007" title="GawrońskaA , DziechciarzP , HorvathA , SzajewskaH . A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children. Alimentary Pharmacology and Therapeutics2007;25(2):177‐84. [DOI: 10.1111/j.1365‐2036.2006.03175.x; PUBMED: 17229242] ">Gawronska 2007</a> assessed school absenteeism (included as a secondary outcome) as a dichotomous measure in 104 children (reported in diaries) and found no difference between control and intervention groups (P = 0.44). In <a href="./references#CD010972-bbs2-0017" title="WeizmanZ , Abu‐AbedJ , BinsztokM . Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double‐blind, placebo‐controlled trial. Journal of Pediatrics2016;4:4. [DOI: 10.1016/j.jpeds.2016.04.003; PUBMED: 27156182] ">Weizman 2016</a>, the 101 included children kept a school absence diary; postintervention there was no significant difference in the number of days of absence between the two groups (2.7 versus 1.9 days per four weeks, in the placebo and the probiotic groups, respectively; P = 0.08). <a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a> assessed "functional changes", which included disruption of social activities, need to see a doctor, use of medications, and days of absence from school, on a three‐point Likert scale. The authors reported that this measure improved significantly in the probiotic group at four weeks' postintervention (2.4 (SD 0.5) in the probiotic group, 1.9 (SD 0.4) in the placebo group; P &lt; 0.001). </p> </section> <section id="CD010972-sec-0102"> <p><b>Social or psychological functioning</b></p> <p><a href="./references#CD010972-bbs2-0011" title="KianifarH , JafariSA , KianiM , AhanchianH , GhasemiSV , GroverZ , et al. Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial. Electronic Physician2015;7(5):1255‐60. [DOI: 10.14661/1255; PMC4590561; PUBMED: 26435825] ">Kianifar 2015</a> included "disruption of social activities" as part of their "functional changes" outcome, the results of which are reported above. </p> </section> <section id="CD010972-sec-0103"> <p><b>Quality of daily life</b></p> <p>In <a href="./references#CD010972-bbs2-0009" title="GuandaliniS , MagazzùG , ChiaroA , LaBalestraV , DiNardoG , GopalanS , et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo‐controlled, double‐blind, crossover study. Journal of Pediatric Gastroenterology and Nutrition2010;51(1):24‐30. [DOI: 10.1097/MPG.0b013e3181ca4d95; PUBMED: 20453678] ">Guandalini 2010</a>, caregivers of 59 children were asked to assess family life disruption; the trial reported improvement in family life disruption after six weeks in the intervention group (P &lt; 0.001), which was not present in the placebo group. <a href="./references#CD010972-bbs2-0008" title="GiannettiE , AlessandrellaA , DeGiovanniD , CampanozziA , StaianoA , MieleE . A multicenter, randomized, double‐blind, placebo controlled, crossover trial on the efficacy of a mixture of three bifidobacteria in children with functional abdominal pain. Digestive and Liver Disease2014;46(Suppl 3):e40. [DOI: 10.1016/j.dld.2014.07.042] GiannettiE , MaglioneM , AlessandrellaA , StrisciuglioC , DeGiovanniD , CampanozziA , et al. A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial. Journal of Clinical Gastroenterology2017;51(1):e5‐10. [DOI: 10.1097/MCG.0000000000000528; PUBMED: 27306945] Newlove‐DelgadoT . Request for study information [personal communication]. Email to: Dr. Staiano 14 November 2016. ">Giannetti 2017</a> used the Functional Disability Assessment to measure quality of life (<a href="./references#CD010972-bbs2-0035" title="ClaarRL , WalkerLS . Functional assessment of pediatric pain patients: psychometric properties of the functional disability inventory. Pain2006;121(1‐2):77‐84. [DOI: 10.1016/j.pain.2005.12.002; PMC3144698; PUBMED: 16480823] ">Claar 2006</a>). An improved quality of life was reported by 46% of children with irritable bowel syndrome after probiotics, versus 16% after placebo (P = 0.002). There was no difference in the functional dyspepsia group. </p> </section> <section id="CD010972-sec-0104"> <p><b>Adverse events</b></p> <p>Ten of the 13 studies included in this comparison reported that the probiotic was well tolerated and that there were no adverse events. In <a href="./references#CD010972-bbs2-0015" title="SaneianH , PourmoghaddasZ , RoohafzaH , GholamrezaeiA . Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children. Gastroenterology and Hepatology From Bed to Bench2015;8(1):56‐65. [PMC4285933; PUBMED: 25584177] ">Saneian 2015</a>, participants were specifically asked about a checklist of adverse effects; the only symptom where there was a significant difference was that of dry mouth, reported by 44% of the intervention group and 23% of the control group. The studies by <a href="./references#CD010972-bbs2-0014" title="SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Clinical Nutrition Supplements2011;6(1):198. [DOI: 10.1016/S1744‐1161(11)70513‐0] SabbiT . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2012;44(Suppl 2):S207‐8. [DOI: 10.1016/S1590‐8658(12)60589‐1] SabbiT , PalumboM . The use of lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial. Digestive and Liver Disease2011;43(Suppl 5):S412. [DOI: 10.1016/S1590‐8658(11)60644‐0] WhearR . Request for data for Cochrane review [personal communication]. Email to: Dr Sabbi 24 April 2014. ">Sabbi 2011</a> and <a href="./references#CD010972-bbs2-0019" title="YoungRJ . Successful probiotic therapy of chronic recurrent abdominal pain in children. AGA Abstracts Gastroenterology1997;112(4):A856. YoungRJ , HannerTL , VanderhoofJA . Therapeutic efficacy of lactobacillus plantarum 299V in chronic recurrent abdominal pain of childhood. Journal of Pediatric Gastroenterology and Nutrition1997;25(4):465. ">Young 1997</a> were reported in abstracts and did not report on adverse events. </p> </section> </section> <section id="CD010972-sec-0105"> <h6 class="title">Results of pooled analyses</h6> <p>No pooled analyses were possible.</p> </section> </section> </section> <section id="CD010972-sec-0106"> <h4 class="title">Comparison 2: Fibre<i>interventions</i> versus placebo </h4> <p>Four studies assessed the effects of fibre in various forms (<a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a>; <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a>; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>; <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>). </p> <section id="CD010972-sec-0107"> <h5 class="title">Primary outcomes</h5> <section id="CD010972-sec-0108"> <h6 class="title">Results of individual studies</h6> <section id="CD010972-sec-0109"> <p><b>Change in pain frequency</b></p> <p><a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> only reported figures for improvement in frequency of pain at six weeks: 13 out of 26 children in the fibre cookie group and 7 out of 26 children in the placebo group experienced the outcome of improvement in pain following intervention (OR 2.71, 95% CI 0.85 to 8.64). No numerical data were given for the other outcome of improved intensity of pain, which was simply described as "not significant". </p> <p>In <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a>, the authors reported a significant reduction in pain frequency in the fibre group compared with the placebo group using the Numerical Rating Scale (NRS‐11) (<a href="./references#CD010972-bbs2-0061" title="McGrathPA , SeifertCE , SpeechleyKN , BoothJC , StittL , GibsonMC . A new analogue scale for assessing children's pain: an initial validation study. Pain1996;64(3):435‐43. [PUBMED: 8783307] ">McGrath 1996</a>) after the six‐week intervention (P = 0.03). </p> </section> <section id="CD010972-sec-0110"> <p><b>Change in pain intensity</b></p> <p>In <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a>, pain intensity was rated at baseline and at eight weeks' follow‐up using the Wong‐Baker FACES Pain Rating Scale (<a href="./references#CD010972-bbs2-0097" title="WongD , BakerC . Pain in children: comparison of assessment scales. Pediatric Nursing1988;14(1):9‐17. [PUBMED: 3344163] ">Wong 1988</a>); whilst there was a greater decrease in intensity in the intervention group, this was not statistically significant at the P &lt; 0.05 level. </p> </section> <section id="CD010972-sec-0111"> <p><b>Improvement in pain</b></p> <p><a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a> measured improvement in pain using the Faces Pain Scale at four weeks (<a href="./references#CD010972-bbs2-0034" title="BieriD , ReeveR , ChampionGD , AddicoatL , ZieglerJ . The Faces Pain Scale for the self‐assessment of the severity of pain experienced by children: development, initial validation and preliminary investigation for ratio scale properties. Pain1990;41:139‐50. [PUBMED: 2367140] ">Bieri 1990</a>): 23 out of 41 children in the intervention arm and 20 out of 43 in the placebo arm experienced the outcome of improvement in pain following intervention (OR 1.47, 95% CI 0.62 to 3.47). </p> </section> </section> <section id="CD010972-sec-0112"> <h6 class="title">Results of pooled analyses</h6> <p>See <a href="./full#CD010972-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD010972-sec-0113"> <p><b>Change in pain frequency</b></p> <p>We were not able to pool data for this outcome as it was either not reported in these studies or there was no equivalent outcome data. </p> </section> <section id="CD010972-sec-0114"> <p><b>Change in pain intensity</b></p> <p>We were able to pool data from <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a> and <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a> in a meta‐analysis for the outcome of change in pain intensity at zero to three months' postintervention. Both studies included only children with irritable bowel syndrome. The SMD of effect across the studies was ‐1.24 (95% CI ‐3.41 to 0.94; Z = 1.11; P = 0.27; 2 studies; 135 children; Tau² = 2.38; Chi² = 28.91; I² = 97%; P for heterogeneity &lt; 0.001; <a href="./references#CD010972-fig-0014" title="">Analysis 2.1</a>). The 95% CIs for the point estimates of SMD in both studies did not overlap, and very high statistical heterogeneity was detected according to Chi² and I² tests. <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a> used a tertiary clinic sample, and <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a> used a mixed population recruited from primary and specialist care. Using GRADE, we downgraded the quality of evidence for this outcome by two levels to low, based on the high levels of heterogeneity and the imprecision of the estimate. </p> </section> <section id="CD010972-sec-0115"> <p><b>Improvement in pain</b></p> <p>We pooled data from <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> and <a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a> (136 children) in a meta‐analysis for the dichotomous outcome of improvement in pain at zero to three months' postintervention. The total number of events in the meta‐analysis was fewer than 70, with a consequently imprecise estimate. The pooled OR was 1.83 (95% CI 0.92 to 3.65; Z = 1.71; P = 0.09; 2 studies; 136 children; Tau² = 0.00; Chi² = 0.69; I² = 0%; P for heterogeneity = 0.40; <a href="./references#CD010972-fig-0015" title="">Analysis 2.2</a>; <a href="#CD010972-fig-0005">Figure 5</a>). Using GRADE, we rated the quality of evidence for this outcome as low due to an unclear risk of bias in a number of domains in the included studies and the small numbers of events (fewer than 100). </p> <div class="figure" id="CD010972-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Fibre versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention." data-id="CD010972-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Fibre versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention. </p> </div> </div> </div> </section> </section> </section> <section id="CD010972-sec-0116"> <h5 class="title">Secondary outcomes</h5> <section id="CD010972-sec-0117"> <h6 class="title">Results of individual studies</h6> <section id="CD010972-sec-0118"> <p><b>School performance</b></p> <p><a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a> reported on the frequency of school absenteeism in 84 children as described by parents (no specific measure reported), and found no significant difference between intervention and control groups (P = 0.56). </p> </section> <section id="CD010972-sec-0119"> <p><b>Social or psychological functioning</b></p> <p>No studies reported data on this outcome.</p> </section> <section id="CD010972-sec-0120"> <p><b>Quality of daily life</b></p> <p><a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a> reported no difference between intervention and control groups in changes in daily activities in 84 children (no measure reported) (P = 0.37). <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a> reported on health‐related quality of life using the Pediatric Quality of Life Generic Core Scales (<a href="./references#CD010972-bbs2-0091" title="VarniJW , BendoCB , DenhamJ , ShulmanRJ , SelfMM , NeigutDA , et al. PedsQL Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls. Quality of Life Research2015;24(2):363–78. [DOI: 10.1007/s11136‐014‐0781‐x; PUBMED: 25148757] ">Varni 2015</a>); no difference was found between the intervention and control groups on child report (P = 0.73) or parent report (P = 0.99). </p> </section> <section id="CD010972-sec-0121"> <p><b>Adverse events</b></p> <p><a href="./references#CD010972-bbs2-0010" title="HorvathA , DziechciarzP , SzajewskaH . Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial. World Journal of Gastroenterology2013;19(20):3062‐8. [DOI: 10.3748/wjg.v19.i20.3062; PMC3662945; PUBMED: 23716985] ">Horvath 2013</a> reported that no adverse events had occurred, although four children in the intervention group complained of symptom exacerbation compared to two in the placebo group; <a href="./references#CD010972-bbs2-0013" title="RomanoC , ComitoD , FamianiA , CalamaràS , LoddoI . Partially hydrolysed guar gum in pediatric functional abdominal pain. World Journal of Gastroenterology2013;19(2):235‐40. [DOI: 10.3748/wjg.v19.i2.235; PMC3547554] ">Romano 2013</a> and <a href="./references#CD010972-bbs2-0016" title="ShulmanR . Request for raw data for Cochrane systematic review [personal communication]. Email to: T Newlove‐Delgado 22 August 2016. ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfM , WeidlerEM , et al. Randomized, double blind trial of psyllium fiber in children with irritable bowel syndrome (IBS). Gastroenterology2015;148(4 Suppl 1):S‐120. [DOI: 10.1016/S0016‐5085(15)30418‐2] ShulmanRJ , HollisterEB , CainK , CzyzewskiDI , SelfMM , WeidlerEM , et al. Psyllium fiber reduces abdominal pain in children with Irritable Bowel Syndrome in a randomized, double‐blind trial. Clinical Gastroenterology and Hepatology2016;9:9. [DOI: 10.1016/j.cgh.2016.03.045; PMC5064811; PUBMED: 27080737] ">Shulman 2016</a> also reported that no adverse events had occurred. <a href="./references#CD010972-bbs2-0005" title="FeldmanW , McGrathP , HodgsonC , RitterH , ShipmanRT . The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial. American Journal of Diseases of Children1985;139(12):1216‐8. [PUBMED: 2998181] ">Feldman 1985</a> did not report adverse events. </p> </section> </section> <section id="CD010972-sec-0122"> <h6 class="title">Results of pooled analyses</h6> <p>No pooled analyses were possible.</p> </section> </section> </section> <section id="CD010972-sec-0123"> <h4 class="title">Comparison 3: Low FODMAP diet versus normal diet</h4> <p>We found only one eligible study that examined the effect of a low FODMAP diet. <a href="./references#CD010972-bbs2-0003" title="ChumpitaziBP , CopeJL , HollisterEB , TsaiCM , McMeansAR , LunaRA , et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics2015;42:418‐27. [DOI: 10.1111/apt.13286; PMC4514898; PUBMED: 26104013] ChumpitaziBP , HollisterEB , CopeJL , LunaRA , VersalovicJ , ShulmanRJ . Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Gastroenterology2015;1(4 Suppl 1):S‐44. [DOI: 10.1016/S0016‐5085(15)30153‐0] ">Chumpitazi 2015</a> compared two days of a low FODMAP diet to two days of a typical American childhood diet (TACD) in 33 children using a cross‐over study design. </p> <section id="CD010972-sec-0124"> <h5 class="title">Primary outcomes</h5> <section id="CD010972-sec-0125"> <h6 class="title">Results of individual studies</h6> <section id="CD010972-sec-0126"> <p><b>Change in pain frequency</b></p> <p>Fewer episodes of abdominal pain per day occurred during the low FODMAP diet versus the control diet (P &lt; 0.05), and compared to baseline, children had fewer daily abdominal pain episodes during the low FODMAP diet (P &lt; 0.01), but more episodes during the control diet (P &lt; 0.01). Exact P values were not reported in the paper. </p> </section> <section id="CD010972-sec-0127"> <p><b>Change in pain intensity</b></p> <p>Median pain severity decreased on both diets in comparison to baseline (low FODMAP diet P &lt; 0.001, TACD P &lt; 0.01; exact P values not reported in the paper). </p> </section> <section id="CD010972-sec-0128"> <p><b>Improvement in pain</b></p> <p>Eight children were categorised as responders (children who had significant improvement in pain on the low FODMAP diet only), 15 as non‐responders (children who did not have significant improvement on the low FODMAP diet or TACD), and 10 as placebo responders (children who improved on both diets or only on the TACD). </p> </section> </section> <section id="CD010972-sec-0129"> <h6 class="title">Results of pooled analyses</h6> <p>No pooled analyses were possible.</p> </section> </section> <section id="CD010972-sec-0130"> <h5 class="title">Secondary outcomes</h5> <section id="CD010972-sec-0131"> <h6 class="title">Results of individual studies</h6> <p>No studies reported data on school performance, social or psychological functioning, or quality of daily life. No adverse effects were reported. </p> </section> <section id="CD010972-sec-0132"> <h6 class="title">Results of pooled analyses</h6> <p>No pooled analyses were possible.</p> </section> </section> </section> <section id="CD010972-sec-0133"> <h4 class="title">Comparison 4: Fructose‐restricted diet versus normal diet</h4> <p>We found only one eligible study that examined the effect of a fructose‐restricted diet. In <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>, children with RAP for more than three months were randomised to two weeks of a fructose‐restricted diet or two weeks of a normal diet. Pain intensity and frequency were measured at baseline and postintervention. </p> <section id="CD010972-sec-0134"> <h5 class="title">Primary outcomes</h5> <section id="CD010972-sec-0135"> <h6 class="title">Results of individual studies</h6> <section id="CD010972-sec-0136"> <p><b>Change in pain frequency</b></p> <p>In <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a>, 37 out of 50 (74%) of children in the intervention group and 29 out of 51 (57%) in the control group reported a reduction in the number of pain episodes per week; both reductions were described as 'statistically significant'. </p> </section> <section id="CD010972-sec-0137"> <p><b>Change in pain intensity</b></p> <p><a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a> reported a significant decrease in pain intensity in the intervention group after treatment (P &lt; 0.001), and no difference in pain intensity in the control group. </p> </section> <section id="CD010972-sec-0138"> <p><b>Improvement in pain</b></p> <p>No studies reported this outcome.</p> </section> </section> <section id="CD010972-sec-0139"> <h6 class="title">Results of pooled analyses</h6> <p>No pooled analyses were possible.</p> </section> </section> <section id="CD010972-sec-0140"> <h5 class="title">Secondary outcomes</h5> <p>No studies reported data on school performance, social or psychological functioning, or quality of daily life. <a href="./references#CD010972-bbs2-0018" title="WirthS , KlodtC , WintermeyerP , BerrangJ , HenselK , LangerT , et al. Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: Results from a prospective randomized trial. Klinische Padiatrie2014;226(5):268‐73. [DOI: 10.1055/s‐0034‐1383653; PUBMED: 25153911] ">Wirth 2014</a> did not report on adverse effects. </p> <section id="CD010972-sec-0141"> <h6 class="title">Results of pooled analyses</h6> <p>No pooled analyses were possible.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010972-sec-0142" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010972-sec-0142"></div> <section id="CD010972-sec-0143"> <h3 class="title" id="CD010972-sec-0143">Summary of main results</h3> <p>We included 19 studies with a total of 1453 participants in this review. With the exception of two studies, all studies assessed a treatment arm of probiotic or fibre‐based interventions against placebo, with an average treatment duration of six weeks. The remaining two studies assessed a dietary intervention (low FODMAP diet or fructose‐restricted diet) against a normal control diet. This update extends the evidence base in this area through the inclusion of 15 new studies, along with four from the original review (<a href="./references#CD010972-bbs2-0100" title="Huertas‐CeballosA , LoganS , BennettC , MacarthurC . Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3] ">Huertas‐Ceballos 2009</a>); 10 pooled analyses were possible. </p> <section id="CD010972-sec-0144"> <h4 class="title">Evidence for probiotic interventions</h4> <p>Overall, the data in this review provided some evidence suggesting that probiotics may be effective in the management of children with RAP, based on the results of 13 studies. Trials used a range of probiotic preparations: five used <i>Lactobacillus rhamnosus</i> GG in slightly different preparations; three used <i>Lactobacillus reuteri;</i> two used <i>Bacillus coagulans</i> with fructo‐oligosaccharides; one used a patented mixture; one used <i>Lactobacillus plantarum</i> ; and one used a mixture of <i>Bifidobacterium</i> species. </p> <p>The majority of studies measured short‐term outcomes at zero to three months' postintervention only. We found that probiotics improved pain in the meta‐analysis of seven probiotic trials at this time point (OR 1.63, 95% CI 1.07 to 2.47; P = 0.02), with an estimated NNTB of eight, meaning that eight children would need to receive probiotics for one to experience improvement in pain in this timescale. The planned sensitivity analysis removing studies where the risk of bias for allocation concealment or blinding of participants and personnel and/or blinding of outcome assessment was high or unclear also found that children treated with probiotics were more likely to experience an improvement in pain (OR 1.95, 95% CI 1.40 to 2.70; P &lt; 0.001). The planned subgroup analysis of children identified as having irritable bowel syndrome only at the same time point resulted in a pooled OR of 3.01 (95% CI 1.77 to 5.13; P &lt; 0.001), and an estimated NNTB of four. </p> <p>For all children, we also found a reduction in pain frequency (SMD ‐0.55, 95% CI ‐0.98 to ‐0.12; P = 0.012) and pain intensity (SMD ‐0.50, 95% CI ‐0.85 to ‐0.15; P = 0.005), in those treated with probiotics compared to placebo at zero to three months' postintervention. </p> <p>We were able to perform only one pooled analysis of two studies for outcomes at three to six months' postintervention, for the outcome of improvement in pain. The pooled OR was 1.94 (95% CI 1.10 to 3.43; P = 0.023), with a NNTB of seven. </p> <p>Using the GRADE approach, we rated the quality of the evidence for all the improvement in pain outcomes as moderate, and the quality of evidence for change in pain frequency and intensity as low. </p> </section> <section id="CD010972-sec-0145"> <h4 class="title">Evidence for fibre interventions</h4> <p>As in the previous version of this review (<a href="./references#CD010972-bbs2-0100" title="Huertas‐CeballosA , LoganS , BennettC , MacarthurC . Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003019.pub3] ">Huertas‐Ceballos 2009</a>), the data in this analysis did not provide convincing evidence suggesting that fibre supplements are effective in RAP, on the grounds of a paucity of studies and a lack of moderate‐ or high‐quality evidence. We performed two meta‐analyses, neither of which found that fibre interventions were effective in improving pain. </p> <p>Only two studies were eligible for inclusion in the meta‐analysis for the outcome of improvement of pain, with a pooled OR of 1.83 (95% CI 0.92 to 3.65; P = 0.09). Two different studies were eligible for pooled analysis for the outcome of change in pain intensity: the SMD of effect across the studies was ‐1.24 (95% CI ‐3.41 to 0.94; P = 0.27); both studies included only children with irritable bowel syndrome. Using GRADE, we assessed the quality of the evidence for both outcomes as low. </p> </section> <section id="CD010972-sec-0146"> <h4 class="title">Evidence for low FODMAP diet and fructose‐restricted diet</h4> <p>We found only one study each that examined the effects of a low FODMAP diet and a fructose‐restricted diet on pain in children with RAP. We were therefore unable to perform any pooled analyses for these two interventions. </p> </section> </section> <section id="CD010972-sec-0147"> <h3 class="title" id="CD010972-sec-0147">Overall completeness and applicability of evidence</h3> <p>There are some important considerations relating to the overall completeness and applicability of the evidence from this study. First, 11 out of 13 included probiotic studies measured outcomes at zero to three months' postintervention only, and most interventions lasted only between four and six weeks. Only two included studies measured outcomes at 12 weeks or more, although the pooled analysis did find that improvement in pain was sustained at this time point. Consequently, the evidence base for the longer‐term effectiveness of probiotics in the included studies needs to be strengthened. Second, we were only able to perform one subgroup analysis by category of RAP, which was for probiotics for children with irritable bowel syndrome. However, the pooled analysis suggested that a significant improvement in pain was experienced by this group at short‐term follow‐up. Third, we were only able to identify one study of low FODMAP diets and one of fructose‐restricted diets eligible for inclusion. A number of RCTs of low FODMAP diets have been conducted in adults with irritable bowel syndrome (<a href="./references#CD010972-bbs2-0064" title="NanayakkaraWS , SkidmorePM , O’BrienL , WilkinsonTJ , GearryRB . Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clinical and Experimental Gastroenterology2016;9:131‐42. [DOI: 10.2147/CEG.S86798; PMC4918736; PUBMED: 27382323] ">Nanayakkara 2016</a>), but it appears that the area of exclusion diets in children requires further research before evidence‐based recommendations regarding the use of these interventions can be made. </p> <p>We would also like to highlight that few studies reported on our secondary outcomes relating to school absence, social or psychological functioning, and quality of life, which represents a gap in the completeness of the evidence base. These 'secondary' outcomes are important, as they are likely to indicate disability and to be highly significant for the child and family. </p> <p>Finally, we also note that the majority of studies took place in paediatric gastroenterology clinics, with three taking place in mixed settings and one in "primary care paediatrics". We were therefore unable to comment on any potential difference in outcome by setting. </p> </section> <section id="CD010972-sec-0148"> <h3 class="title" id="CD010972-sec-0148">Quality of the evidence</h3> <p>The overall quality of evidence within this review as assessed by the GRADE approach ranged from 'low' to 'moderate'. We rated the quality of the evidence for the three improvement in pain outcomes in the probiotic and placebo comparison as moderate, downgrading for imprecision or heterogeneity. This means we judged that further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. We rated the quality of the evidence for the change in pain frequency and intensity outcomes for the same comparison as being low due to significant levels of heterogeneity and risk of bias introduced by incomplete outcome data. This means that future research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p>In the case of the two pooled analyses comparing fibre interventions to placebo, we rated the quality of the evidence as low due to significant heterogeneity, imprecision, and an unclear risk of bias in a number of domains in the included studies. Future research in this area is therefore very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </section> <section id="CD010972-sec-0149"> <h3 class="title" id="CD010972-sec-0149">Potential biases in the review process</h3> <p>We conducted a comprehensive search of electronic databases, but did not find sufficient studies to perform a formal assessment of the likelihood of publication bias; consequently it is possible that smaller studies may have been missed. Two review authors independently carried out screening and 'Risk of bias' assessments, discussing any areas of disagreement with another review author. Two review authors also checked data extraction. The methods used were therefore unlikely to introduce bias. </p> </section> <section id="CD010972-sec-0150"> <h3 class="title" id="CD010972-sec-0150">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are in keeping with other systematic reviews of dietary interventions in RAP. <a href="./references#CD010972-bbs2-0052" title="HorvathA , DziechciarzP , SzajewskaH . Meta‐analysis: Lactobacillus rhamnosus GG for abdominal pain‐related functional gastrointestinal disorders in childhood. Alimentary Pharmacology and Therapeutics2011;33(12):1302‐10. [DOI: 10.1111/j.1365‐2036.2011.04665.x; PUBMED: 21507030] ">Horvath 2011</a>, and more recently <a href="./references#CD010972-bbs2-0075" title="RuttenJMTM , KorterinkJJ , VenmansLMAJ , BenningaMA , TabbersMM . Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review. Pediatrics2015;135(3):522‐35. [DOI: 10.1542/peds.2014‐2123] ">Rutten 2015</a>, reported that <i>Lactobacillus rhamnosus</i> GG was associated with significantly more treatment responders than placebo in their meta‐analyses; the same authors found only inconclusive data regarding the effects of fibre supplements (<a href="./references#CD010972-bbs2-0053" title="HorvathA , DziechciarzP , SzajewskaH . Systematic review of randomized controlled trials: fiber supplements for abdominal pain‐related functional gastrointestinal disorders in childhood. Annals of Nutrition and Metabolism2012;61(2):95‐101. [PUBMED: 22889919] ">Horvath 2012</a>; <a href="./references#CD010972-bbs2-0075" title="RuttenJMTM , KorterinkJJ , VenmansLMAJ , BenningaMA , TabbersMM . Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review. Pediatrics2015;135(3):522‐35. [DOI: 10.1542/peds.2014‐2123] ">Rutten 2015</a>). </p> <section id="CD010972-sec-0151"> <h4 class="title">Issues for consideration</h4> <p>We rated the quality of the evidence provided by the included studies as moderate or low (for probiotics) or low (for fibre). There were additionally further issues for consideration. As discussed above, the majority of studies were short term. We also noted variety in the definition and scales used to assess improvement in pain, meaning that this outcome does not reflect a universally agreed clinically significant benchmark. It is therefore harder to draw conclusions as to whether the reported improvements in pain were clinically meaningful, although this is to some extent a matter of judgement. The outcome of improvement in pain in most included studies represented either a change to no pain or a decrease by 50%, which could be argued to be clinically important. This observation also applied to the assessment of other outcomes, such as pain intensity and frequency. </p> <p>As previously mentioned, many studies did not collect data on the prespecified secondary outcomes of interest, such as school performance or quality of daily life, meaning that the effect of dietary interventions on these important outcomes was not measured and that it was therefore not possible to conduct pooled analyses. Data on these outcomes would also assist in determining the clinical relevance of improvements in pain. </p> <p>We performed no subgroup analyses by type or concentration of probiotic, as we did not specify this in our protocol (<a href="./references#CD010972-bbs2-0101" title="MartinAE , Newlove‐DelgadoTV , AbbottRA , BethelA , Thompson‐CoonJ , NikolaouV , et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010972] ">Martin 2014b</a>); each pooled analysis included studies using different strains of probiotic, the most common being <i>L rhamnosus</i> GG and <i>L reuteri.</i> </p> <p>Finally, the majority of studies included children under the broad umbrella of RAP and did not present results by RAP subtype. Consequently, we were only able to perform one pooled analysis for the subtype of irritable bowel syndrome for probiotic interventions, although the eligible studies for the pooled analysis for pain intensity in fibre interventions also included only children with irritable bowel syndrome. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010972-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram" data-id="CD010972-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010972-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010972-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Probiotics versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention." data-id="CD010972-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Probiotics versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Fibre versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention." data-id="CD010972-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Fibre versus placebo, outcome: Improvement in pain 0 to 3 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 1 Change in pain frequency: 0 to 3 months' postintervention." data-id="CD010972-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 1 Change in pain frequency: 0 to 3 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 2 Change in pain frequency: 0 to 3 months' postintervention. Sensitivity analysis." data-id="CD010972-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 2 Change in pain frequency: 0 to 3 months' postintervention. Sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 3 Change in pain intensity: 0 to 3 months' postintervention." data-id="CD010972-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 3 Change in pain intensity: 0 to 3 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 4 Change in pain intensity: 0 to 3 months' postintervention. Sensitivity analysis." data-id="CD010972-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 4 Change in pain intensity: 0 to 3 months' postintervention. Sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 5 Improvement in pain: 0 to 3 months' postintervention." data-id="CD010972-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 5 Improvement in pain: 0 to 3 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 6 Improvement in pain: 0 to 3 months' postintervention. Sensitivity analysis." data-id="CD010972-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 6 Improvement in pain: 0 to 3 months' postintervention. Sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 7 Improvement in pain: 0 to 3 months' postintervention. Subgroup analysis (irritable bowel syndrome)." data-id="CD010972-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 7 Improvement in pain: 0 to 3 months' postintervention. Subgroup analysis (irritable bowel syndrome). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics versus placebo, Outcome 8 Improvement in pain: 3 to 6 months' postintervention." data-id="CD010972-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Probiotics versus placebo, Outcome 8 Improvement in pain: 3 to 6 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Fibre versus placebo, Outcome 1 Change in pain intensity: 0 to 3 months' postintervention." data-id="CD010972-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Fibre versus placebo, Outcome 1 Change in pain intensity: 0 to 3 months' postintervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010972-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/urn:x-wiley:14651858:media:CD010972:CD010972-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_t/tCD010972-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Fibre versus placebo, Outcome 2 Improvement in pain: 0 to 3 months' postintervention." data-id="CD010972-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Fibre versus placebo, Outcome 2 Improvement in pain: 0 to 3 months' postintervention.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/media/CDSR/CD010972/image_n/nCD010972-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010972-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Probiotics compared to placebo for recurrent abdominal pain in childhood</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Probiotics compared to placebo for recurrent abdominal pain in childhood</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Children with recurrent abdominal pain<br/> <b>Settings:</b> Mixed settings, including paediatric gastroenterology clinics<br/> <b>Intervention:</b> Probiotics<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in pain frequency: 0 to 3 months' postintervention</b> </p> <p>Different measures were used to assess pain frequency, such as a visual analogue scale and the Wong‐Baker FACES Pain Rating Scale (<a href="./references#CD010972-bbs2-0061" title="McGrathPA , SeifertCE , SpeechleyKN , BoothJC , StittL , GibsonMC . A new analogue scale for assessing children's pain: an initial validation study. Pain1996;64(3):435‐43. [PUBMED: 8783307] ">McGrath 1996</a>; <a href="./references#CD010972-bbs2-0097" title="WongD , BakerC . Pain in children: comparison of assessment scales. Pediatric Nursing1988;14(1):9‐17. [PUBMED: 3344163] ">Wong 1988</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain frequency: 0 to 3 months' postintervention scores in the intervention groups was <b>0.55 SDs lower</b> (0.98 to 0.12 lower). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>523<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SD represents a small difference, 0.5 SD a moderate difference, and 0.8 SD a large difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in pain intensity: 0 to 3 months' postintervention</b> </p> <p>Different measures were used to assess pain intensity, as above.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain intensity: 0 to 3 months' postintervention scores in the intervention groups was <b>0.50 SDs lower</b> (0.85 to 0.15 lower). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>575<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As a rule of thumb, 0.2 SD represents a small difference, 0.5 SD a moderate difference, and 0.8 SD a large difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 0 to 3 months' postintervention</b> </p> <p>Different measures and definitions were used for improvement in pain, such as Likert scale, visual analogue scale, and Subject’s Global Assessment of Relief Scale (<a href="./references#CD010972-bbs2-0061" title="McGrathPA , SeifertCE , SpeechleyKN , BoothJC , StittL , GibsonMC . A new analogue scale for assessing children's pain: an initial validation study. Pain1996;64(3):435‐43. [PUBMED: 8783307] ">McGrath 1996</a>; <a href="./references#CD010972-bbs2-0063" title="Müller‐LissnerS , KochG , TalleyNJ , DrossmanD , RueeggP , Dunger‐BaldaufC , et al. Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome‐related symptoms in clinical trials. Journal of Clinical Epidemiology2003;56(4):310‐6. [PUBMED: 12767407] ">Muller‐Lissner 2003</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>421 per 1000</b><sup>3</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>542 per 1000</b> <br/> (438 to 642) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.63</b> <br/> (1.07 to 2.47) </p> <p>NNTB = 8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>722<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 0 to 3 months' postintervention Subgroup (irritable bowel syndrome)</b> </p> <p>Different measures were used to assess improvement in pain, as above.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>359 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>627 per 1000</b> <br/> (498 to 742) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 3.01</b> <br/> (1.77 to 5.13) </p> <p>NNTB = 4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>344<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 3 to 6 months' postintervention</b> </p> <p>Different measures were used to assess improvement in pain, as above.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>589 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>736 per 1000</b> <br/> (612 to 831) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.94</b> <br/> (1.10 to 3.43) </p> <p>NNTB = 7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>224<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NNTB</b> : number needed to treat for an additional beneficial outcome, based on the absolute risk reduction between the intervention and comparison group probable outcomes; <b>OR:</b> odds ratio; <b>SD:</b> standard deviation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level due to incomplete outcome data in a number of included studies leading to an unclear or high risk of bias.<br/> <sup>2</sup>Downgraded one level for evidence of significant heterogeneity (I² &gt; 70%; Chi² P &lt; 0.001).<br/> <sup>3</sup>Assumed risk is based on the mean outcome of the control groups in all included studies.<br/> <sup>4</sup>Downgraded one level due to evidence of heterogeneity (I² = 45%; Chi² P = 0.09).<br/> <sup>5</sup>Downgraded one level for imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Probiotics compared to placebo for recurrent abdominal pain in childhood</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010972-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Fibre versus placebo for recurrent abdominal pain in childhood</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Fibre versus placebo for recurrent abdominal pain in childhood</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Children with recurrent abdominal pain<br/> <b>Settings:</b> Mixed settings, predominantly outpatient gastroenterology clinics<br/> <b>Intervention:</b> Fibre </p> <p><b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Fibre</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in pain intensity: 0 to 3 months' postintervention</b> </p> <p>Pain intensity was measured using different scales in the 2 included studies: the Wong Baker FACES Pain Rating Scale, <a href="./references#CD010972-bbs2-0097" title="WongD , BakerC . Pain in children: comparison of assessment scales. Pediatric Nursing1988;14(1):9‐17. [PUBMED: 3344163] ">Wong 1988</a>, and the Numerical Rating Scale (<a href="./references#CD010972-bbs2-0092" title="vonBaeyerCL , SpagrudLJ , McCormickJC , ChooE , NevilleK , ConnellyMA . Three new datasets supporting use of the Numerical Rating Scale (NRS‐11) for children’s self‐reports of pain intensity. Pain2009;143(3):223‐7. [DOI: 10.1016/j.pain.2009.03.002; PUBMED: 19359097] ">von Baeyer 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in pain intensity 0 to 3 months' postintervention score in the intervention groups was <b>1.24 SDs lower</b> (3.41 lower to 0.94 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Improvement in pain: 0 to 3 months' postintervention</b> </p> <p>Improvement in pain was defined and measured differently in the 2 included studies: using a "stomach ache diary" and the Faces Pain Scale (<a href="./references#CD010972-bbs2-0034" title="BieriD , ReeveR , ChampionGD , AddicoatL , ZieglerJ . The Faces Pain Scale for the self‐assessment of the severity of pain experienced by children: development, initial validation and preliminary investigation for ratio scale properties. Pain1990;41:139‐50. [PUBMED: 2367140] ">Bieri 1990</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>391 per 1000</b><sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>541 per 1000</b> <br/> (372 to 701) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.83</b> <br/> (0.92 to 3.65) </p> <p>NNTB = 6.7</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NNTB:</b> number needed to treat for an additional beneficial outcome, based on the absolute risk reduction between the intervention and comparison group probable outcomes; <b>OR:</b> odds ratio; <b>SD:</b> standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Assumed risk in control group is based on the mean outcome of the control group in the two included studies.<br/> <sup>2</sup>Downgraded one level due to imprecision.<br/> <sup>3</sup>Downgraded one level due to evidence of significant heterogeneity.<br/> <sup>4</sup>Downgraded one level, as one study contained insufficient information regarding allocation concealment, outcome assessment, and selective reporting. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Fibre versus placebo for recurrent abdominal pain in childhood</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010972-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Assessment of risk of bias in included studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Domain</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>'Risk of bias' judgement</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Low</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Unclear</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Selection bias </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Random sequence generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details any of the following methods: simple randomisation (such as coin‐tossing, throwing dice, or dealing previously shuffled cards, a list of random numbers, or computer‐generated random numbers) or restricted randomisation (blocked, ideally with varying block sizes or stratified groups, provided that within‐groups randomisation is not affected). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details no randomisation or other inadequate method such as alternation, assignment based on date of birth, case record number, and date of presentation. These may be referred to as ‘quasi‐random’. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias.</p> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allocation concealment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details concealed allocation sequence in sufficient detail to determine that allocations could not have been foreseen in advance of or during enrolment. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details a method where the allocation is known prior to assignment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Performance bias </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding of participants and personnel</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details a method of blinding the participants and personnel. This requires sufficient detail to show they were unable to identify the therapeutic intervention from the control intervention. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Considering the nature of the interventions, it may not be possible to blind the participants and therapists. The effect of this will be addressed in the Discussion. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Detection bias </b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blinding of outcome assessment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study details a blinded outcome assessment. This may only be possible for outcomes that are externally assessed. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the outcome assessment is not blinded. We expect this may be unavoidable for self rated outcomes of unblinded interventions. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias.</p> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Attrition bias</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incomplete outcome data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the study reports attrition and exclusions, including the numbers in each intervention group (compared with total randomised participants), reasons for attrition or exclusions, and any re‐inclusions. Also, the impact of missing data is not believed to alter the conclusions, and there are acceptable reasons for the missing data. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We may judge the risk of attrition bias to be high due to the amount, nature, or handling (such as per‐protocol analysis) of incomplete outcome data. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias, e.g. if the number of people randomised to each treatment is not reported. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Reporting bias</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Selective outcome reporting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is judged to be complete reporting, which will be found on comparison of the published study and protocol, if available. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If the reporting is selective, so that some outcome data are not reported.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of bias, such as the protocol is not available. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Other sources of bias</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assessment of other sources of bias in other domains not covered by the tool, including validity of outcome measures utilised </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is judged to be no other factors that would be likely to introduce major potential bias. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If other factors are identified that are judged to represent a high risk of bias.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If there is insufficient detail to judge the risk of other bias.</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Assessment of risk of bias in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/full#CD010972-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010972-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Probiotics versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in pain frequency: 0 to 3 months' postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐0.98, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in pain frequency: 0 to 3 months' postintervention. Sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐0.94, ‐0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in pain intensity: 0 to 3 months' postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐0.85, ‐0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in pain intensity: 0 to 3 months' postintervention. Sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>441</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐1.05, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Improvement in pain: 0 to 3 months' postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>722</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.07, 2.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Improvement in pain: 0 to 3 months' postintervention. Sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [1.40, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Improvement in pain: 0 to 3 months' postintervention. Subgroup analysis (irritable bowel syndrome) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.01 [1.77, 5.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Improvement in pain: 3 to 6 months' postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [1.10, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Probiotics versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010972-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Fibre versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in pain intensity: 0 to 3 months' postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐3.41, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Improvement in pain: 0 to 3 months' postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [0.92, 3.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Fibre versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010972.pub2/references#CD010972-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010972.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010972-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010972-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010972-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010972-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD010972-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010972-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD010972-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010972-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010972\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010972\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010972\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010972\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010972\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010972.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010972.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010972.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010972.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010972.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717461430"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010972.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717461434"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010972.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db87a9a639365',t:'MTc0MDcxNzQ2MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 